<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="iso-abbrev">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="publisher-id">rbccv</journal-id><journal-title-group><journal-title>Brazilian Journal of Cardiovascular Surgery</journal-title></journal-title-group><issn pub-type="ppub">0102-7638</issn><issn pub-type="epub">1678-9741</issn><publisher><publisher-name>Sociedade Brasileira de Cirurgia Cardiovascular</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">28492794</article-id><article-id pub-id-type="pmc">5409260</article-id><article-id pub-id-type="doi">10.21470/1678-9741-2016-0085</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title>Exploring Vascular Function Biomarkers: Implications for
Rehabilitation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Phillips</surname><given-names>Shane A.</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Andaku</surname><given-names>Daniela Kuguimoto</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Mendes</surname><given-names>Renata Gon&#x000e7;alves</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Caruso</surname><given-names>Fl&#x000e1;via Rossi</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Cabiddu</surname><given-names>Ramona</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Jaenisch</surname><given-names>Rodrigo Boemo</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Arena</surname><given-names>Ross</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Borghi-Silva</surname><given-names>Audrey</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="corresp" rid="c1"/></contrib></contrib-group><aff id="aff1"><label>1</label>Department of Physical Therapy, Integrative Physiology Laboratory,
College of Applied Health Sciences, University of Illinois at Chicago, Chicago, IL,
USA.</aff><aff id="aff2"><label>2</label>Cardiopulmonary Physiotherapy Laboratory, Department of
Physiotherapy, Universidade Federal de S&#x000e3;o Carlos (UFSCAR), S&#x000e3;o
Carlos, SP, Brazil.</aff><author-notes><corresp id="c1">Correspondence Address: Audrey Borghi-Silva, Universidade Federal
de S&#x000e3;o Carlos - Physical Therapy, Rod. Washington Luiz, km 235 S&#x000e3;o
Carlos, SP, Brazil - Zip code: 13565-905. E-mail:
<email>audrey@ufscar.br</email></corresp></author-notes><pub-date pub-type="epub-ppub"><season>Mar-Apr</season><year>2017</year></pub-date><!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' --><pub-date pub-type="ppub"><season>Mar-Apr</season><year>2017</year></pub-date><volume>32</volume><issue>2</issue><fpage>125</fpage><lpage>135</lpage><history><date date-type="received"><day>27</day><month>12</month><year>2016</year></date><date date-type="accepted"><day>07</day><month>1</month><year>2017</year></date></history><permissions><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an Open Access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is
properly cited.</license-p></license></permissions><abstract><p>The endothelium plays an important role in maintaining vascular homeostasis and
regulating blood vessel function. Endothelial function is considered an
independent predictor for risk of future cardiovascular events in cardiovascular
and non-cardiovascular patients, as well as a predictor for postoperative
complications in cardiovascular surgery patients. Brachial artery flow-mediated
dilation by high-resolution ultrasound is widely used to evaluate
endothelium-dependent vasodilation, which is mainly mediated by nitric oxide
release. Physical exercise exerts beneficial effects on endothelial function and
can be used in both primary and secondary prevention of cardiac and peripheral
artery diseases, even in the postoperative period of cardiovascular surgery.</p></abstract><kwd-group><kwd>Rehabilitation</kwd><kwd>Atherosclerosis</kwd><kwd>Endothelium</kwd></kwd-group></article-meta></front><body><table-wrap id="t3" orientation="portrait" position="anchor"><table frame="hsides" rules="groups"><colgroup span="1"><col width="8%" span="1"/><col width="40%" span="1"/><col width="4%" span="1"/><col width="8%" span="1"/><col width="40%" span="1"/></colgroup><thead><tr><th colspan="2" align="left" style="background-color:#e6e7e8" rowspan="1">Abbreviations,
acronyms &#x00026; symbols</th><th align="left" rowspan="1" colspan="1">&#x000a0;</th><th colspan="2" align="left" style="background-color:#e6e7e8" rowspan="1">&#x000a0;</th></tr></thead><tbody><tr><td style="background-color:#e6e7e8" align="left" rowspan="1" colspan="1">CAD</td><td style="background-color:#e6e7e8" align="left" rowspan="1" colspan="1">= Coronary artery
disease</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td style="background-color:#e6e7e8" align="left" rowspan="1" colspan="1">HIAE</td><td style="background-color:#e6e7e8" align="left" rowspan="1" colspan="1">= High intensity interval
aerobic exercise</td></tr><tr><td style="background-color:#e6e7e8" align="left" rowspan="1" colspan="1">CAE</td><td style="background-color:#e6e7e8" align="left" rowspan="1" colspan="1">= Continuous moderate
intensity aerobic exercise</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td style="background-color:#e6e7e8" align="left" rowspan="1" colspan="1">IMT</td><td style="background-color:#e6e7e8" align="left" rowspan="1" colspan="1">= Intima-media
thickness</td></tr><tr><td style="background-color:#e6e7e8" align="left" rowspan="1" colspan="1">CHS</td><td style="background-color:#e6e7e8" align="left" rowspan="1" colspan="1">= Cardiovascular Health
Study</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td style="background-color:#e6e7e8" align="left" rowspan="1" colspan="1">LVEF</td><td style="background-color:#e6e7e8" align="left" rowspan="1" colspan="1">= Left ventricular
ejection fraction</td></tr><tr><td style="background-color:#e6e7e8" align="left" rowspan="1" colspan="1">CV</td><td style="background-color:#e6e7e8" align="left" rowspan="1" colspan="1">= Cardiovascular</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td style="background-color:#e6e7e8" align="left" rowspan="1" colspan="1">MI</td><td style="background-color:#e6e7e8" align="left" rowspan="1" colspan="1">= Myocardial
infarction</td></tr><tr><td style="background-color:#e6e7e8" align="left" rowspan="1" colspan="1">CVD</td><td style="background-color:#e6e7e8" align="left" rowspan="1" colspan="1">= Cardiovascular
disease</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td style="background-color:#e6e7e8" align="left" rowspan="1" colspan="1">NADH</td><td style="background-color:#e6e7e8" align="left" rowspan="1" colspan="1">= Nicotinamide adenine
dinucleotide</td></tr><tr><td style="background-color:#e6e7e8" align="left" rowspan="1" colspan="1">CPB</td><td style="background-color:#e6e7e8" align="left" rowspan="1" colspan="1">= Cardiopulmonary
bypass</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td style="background-color:#e6e7e8" align="left" rowspan="1" colspan="1">NADPH</td><td style="background-color:#e6e7e8" align="left" rowspan="1" colspan="1">= Nicotinamide adenine
dinucleotide phosphate</td></tr><tr><td style="background-color:#e6e7e8" align="left" rowspan="1" colspan="1">CR</td><td style="background-color:#e6e7e8" align="left" rowspan="1" colspan="1">= Cardiac
rehabilitation</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td style="background-color:#e6e7e8" align="left" rowspan="1" colspan="1">NO</td><td style="background-color:#e6e7e8" align="left" rowspan="1" colspan="1">= Nitric oxide</td></tr><tr><td style="background-color:#e6e7e8" align="left" rowspan="1" colspan="1">EDCF</td><td style="background-color:#e6e7e8" align="left" rowspan="1" colspan="1">= Endothelium-derived
contracting factors</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td style="background-color:#e6e7e8" align="left" rowspan="1" colspan="1">OH.</td><td style="background-color:#e6e7e8" align="left" rowspan="1" colspan="1">= Hydroxyl radicals</td></tr><tr><td style="background-color:#e6e7e8" align="left" rowspan="1" colspan="1">EDHF</td><td style="background-color:#e6e7e8" align="left" rowspan="1" colspan="1">= Endothelium-derived
hyperpolarizing factor</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td style="background-color:#e6e7e8" align="left" rowspan="1" colspan="1">PAD</td><td style="background-color:#e6e7e8" align="left" rowspan="1" colspan="1">= Peripheral arterial
disease</td></tr><tr><td style="background-color:#e6e7e8" align="left" rowspan="1" colspan="1">EDRF</td><td style="background-color:#e6e7e8" align="left" rowspan="1" colspan="1">= Endothelium-derived
relaxing factors</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td style="background-color:#e6e7e8" align="left" rowspan="1" colspan="1">PCI</td><td style="background-color:#e6e7e8" align="left" rowspan="1" colspan="1">= Percutaneous coronary
intervention</td></tr><tr><td style="background-color:#e6e7e8" align="left" rowspan="1" colspan="1">EDV</td><td style="background-color:#e6e7e8" align="left" rowspan="1" colspan="1">= Endothelium-dependent
vasomotion</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td style="background-color:#e6e7e8" align="left" rowspan="1" colspan="1">PGI<sub>2</sub></td><td style="background-color:#e6e7e8" align="left" rowspan="1" colspan="1">= Prostaglandin
I<sub>2</sub></td></tr><tr><td style="background-color:#e6e7e8" align="left" rowspan="1" colspan="1">eNOS</td><td style="background-color:#e6e7e8" align="left" rowspan="1" colspan="1">= Endothelial NO
synthase</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td style="background-color:#e6e7e8" align="left" rowspan="1" colspan="1">ROS</td><td style="background-color:#e6e7e8" align="left" rowspan="1" colspan="1">= Reactive oxygen
species</td></tr><tr><td style="background-color:#e6e7e8" align="left" rowspan="1" colspan="1">ET-1</td><td style="background-color:#e6e7e8" align="left" rowspan="1" colspan="1">= Endothelin-1</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td style="background-color:#e6e7e8" align="left" rowspan="1" colspan="1">SOD</td><td style="background-color:#e6e7e8" align="left" rowspan="1" colspan="1">= Superoxide
dismutase</td></tr><tr><td style="background-color:#e6e7e8" align="left" rowspan="1" colspan="1">FMD</td><td style="background-color:#e6e7e8" align="left" rowspan="1" colspan="1">= Flow-mediated
dilation</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td style="background-color:#e6e7e8" align="left" rowspan="1" colspan="1">uAP</td><td style="background-color:#e6e7e8" align="left" rowspan="1" colspan="1">= Unstable angina
pectoris</td></tr><tr><td style="background-color:#e6e7e8" align="left" rowspan="1" colspan="1">GPx</td><td style="background-color:#e6e7e8" align="left" rowspan="1" colspan="1">= Glutathione
peroxidase</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td style="background-color:#e6e7e8" align="left" rowspan="1" colspan="1">VEGF</td><td style="background-color:#e6e7e8" align="left" rowspan="1" colspan="1">= Vascular endothelial
growth factor</td></tr><tr><td style="background-color:#e6e7e8" align="left" rowspan="1" colspan="1">H<sub>2</sub>O<sub>2</sub></td><td style="background-color:#e6e7e8" align="left" rowspan="1" colspan="1">= Hydrogen peroxide</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td style="background-color:#e6e7e8" align="left" rowspan="1" colspan="1">VTI</td><td style="background-color:#e6e7e8" align="left" rowspan="1" colspan="1">= Velocity time
integral</td></tr></tbody></table></table-wrap><sec sec-type="intro"><title>INTRODUCTION</title><sec><title>The Role of the Endothelium in Regulating Vascular Health</title><p>The endothelium is the first line of defense of end-organs against external
aggression and plays an important role in maintaining vascular
homeostasis<sup>[<xref rid="r1" ref-type="bibr">1</xref>]</sup>.
Endothelial cells control vascular function by responding to various hormones,
neurotransmitters and vasoactive factors which affect vasomotion, thrombosis,
platelet aggregation and inflammation<sup>[<xref rid="r2" ref-type="bibr">2</xref>]</sup>. The endothelium mediates the vasomotor tone of the
circulation in response to various chemical (acetylcholine, ACh) or physical
(shear stress) stimuli<sup>[<xref rid="r3" ref-type="bibr">3</xref>]</sup>, by
synthesizing and releasing different vasodilator and vasoconstrictor mediators.
There are endothelium-derived relaxing factors (EDRF), including nitric oxide
(NO), prostaglandin I<sub>2</sub> (PGI<sub>2</sub>), and endothelium-derived
hyperpolarizing factor (EDHF), but also endothelium-derived contracting factors
(EDCF), including endothelin-1 (ET-1) representing the most potent molecule.</p></sec><sec><title>Mechanisms of Vasodilator Function</title><p>NO has been shown to play an important role in the maintenance of basal
vasodilator tone of the blood vessels and plays a key role in
vasodilation<sup>[<xref rid="r4" ref-type="bibr">4</xref>]</sup>. It
also prevents platelet adhesion and aggregation, as well as leukocyte adhesion
and migration into the arterial wall and inhibits smooth muscle cell
proliferation and intimal migration, oxidation of LDL cholesterol, apoptosis of
smooth muscle cells, all key events in the development of
atherosclerosis<sup>[<xref rid="r2" ref-type="bibr">2</xref>]</sup>.</p></sec><sec><title>Mechanism of Flow-Mediated Vasodilation</title><p>Flow-mediated dilation (FMD) is a physiologically important stimulus regulating
vascular tone and homeostasis of the peripheral circulation. This important
endothelial mechanism of vasodilation occurs in virtually every vascular bed. In
large arteries, FMD may be critical for preventing atherosclerosis through
release NO. In humans, a reduction in FMD is prognostic of cardiovascular
disease (CVD). Animal studies have reported that the contribution of NO to FMD
is reduced as oxidative stress increases in the presence of risk factors for
CVD<sup>[<xref rid="r5" ref-type="bibr">5</xref>]</sup>. In humans,
<italic>in vivo</italic> and <italic>in vitro</italic> studies have
demonstrated that relaxant factor(s), other than NO, compensate to maintain FMD
when NO availability is reduced<sup>[<xref rid="r6" ref-type="bibr">6</xref>]</sup>. Altered endothelium-dependent FMD is a hallmark of the
development of CVD and is an initiating event in the development of
atherosclerotic heart disease<sup>[<xref rid="r7" ref-type="bibr">7</xref>]</sup>. During coronary artery disease (CAD), arterioles exhibit
altered endothelium-dependent vasodilation<sup>[<xref rid="r8" ref-type="bibr">8</xref>]</sup>. In humans, Phillips et al.<sup>[<xref rid="r6" ref-type="bibr">6</xref>]</sup> have shown that hydrogen peroxide
(H<sub>2</sub>O<sub>2</sub>) replaces NO as the mediator of
endothelium-dependent flow-induced dilation in resistance arteries of visceral
fat in the presence of CAD. An increase in oxidative stress appears to be a
major mechanism underlying the development of vascular endothelial dysfunction.
The dominant mechanism responsible for endothelial dysfunction is the decrease
in bioavailable NO, as well as the increase in reactive oxygen species (ROS)
production. The generation of ROS in the endothelium includes anions
(O<sub>2</sub>), hydroxyl radicals (OH<sup>.</sup>) and hydrogen peroxide
(H<sub>2</sub>O<sub>2</sub>). ROS modulate vascular tone by several
mechanisms; directly act as EDCF or indirectly potentiate EDCF mediated
responses by reducing the bioavailability of NO. ROS might interact with NO and
reduce its bioavailability via different pathways: direct NO inactivation by
superoxide with peroxynitrite (ONOO<sup>-</sup>) formation; reduction in NO
synthase expression and activity due to changes in their substrate or cofactors,
and also endothelial NOS uncoupling<sup>[<xref rid="r9" ref-type="bibr">9</xref>]</sup>.</p></sec><sec><title>Methods in Evaluating Peripheral Vascular Function</title><sec><title>Rationale for Measuring Peripheral Arterial Function</title><p>The endothelium occupies a unique position in that it is able to secrete a
variety of vasoactive molecules and is also exposed to direct vascular
injury. It is thus an important mediator of atherosclerosis formation and is
widely perceived to be a metric of vascular risk. Previous studies have
demonstrated a correlation between measures of coronary vasodilator function
and FMD<sup>[<xref rid="r10" ref-type="bibr">10</xref>]</sup>. Early studies
established that attenuated vascular responses occur prior to the
development of atherosclerosis in response to a milieu of risk factors, thus
making measurements attractive as a screening tool for cardiovascular (CV)
risk<sup>[<xref rid="r7" ref-type="bibr">7</xref>]</sup>.
Endothelial function is dynamic and can be attenuated rapidly in response to
acute oxidative stress (cigarette smoking, high fat load). In addition,
interventions that are associated with a decrease in vascular risk will
improve vasodilation within a period of months allowing one to determine the
impact of novel interventions in a timely fashion<sup>[<xref rid="r11" ref-type="bibr">11</xref>]</sup>.</p></sec></sec><sec><title>Non-invasive Conduit Vessel Endothelial Function</title><sec><title>Brachial artery FMD</title><p>Celermajer et al.<sup>[<xref rid="r12" ref-type="bibr">12</xref>]</sup>
showed the first report of the measurement of peripheral artery FMD in 1992.
Not only were they able to describe a new method, but also demonstrated that
children with familial hypercholesterolemia had impaired function at an
early age. Since then thousands of studies have been reported using this
methodology. The guidelines for measuring brachial artery FMD are summarized
previously<sup>[<xref rid="r3" ref-type="bibr">3</xref>]</sup>.
Briefly, a high resolution (&#x0003e; 10 MHz) linear array ultrasound probe is
used to longitudinally image the brachial (or radial) artery at rest. A thin
blood pressure (BP) cuff is inflated to supra-systolic pressure for 5
minutes on either the forearm or on the upper arm. After the cuff is
released, the artery dilates in response to shear stress mediated NO release
and maximum dilation typically occurs between 45 and 120 seconds<sup>[<xref rid="r13" ref-type="bibr">13</xref>]</sup>. After a 5 minutes
recovery period, sublingual nitroglycerine may be given to assess
endothelium-independent dilation. The FMD response has been shown to be
mediated mainly by NO, thus it reflects endothelium-dependent
vasodilation<sup>[<xref rid="r14" ref-type="bibr">14</xref>]</sup>.
Two large cohort studies, the Cardiovascular Health Study (CHS)<sup>[<xref rid="r15" ref-type="bibr">15</xref>]</sup> and the Multi-ethnic
Study of Atherosclerosis<sup>[<xref rid="r16" ref-type="bibr">16</xref>]</sup>, demonstrated that FMD was an independent predictor of
CV outcomes. FMD remains the standard tool for research studies designed
understand the effects of novel risk factors or treatments on peripheral
artery conduit vessel function. Main recommendations for brachial artery
flow-mediated dilation measurement are in <xref ref-type="table" rid="t1">Table 1</xref>.</p><table-wrap id="t1" orientation="portrait" position="float"><label>Table 1</label><caption><p>Recommendations for brachial artery flow-mediated dilation
measurement.</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col width="100%" span="1"/></colgroup><tbody><tr><td align="left" rowspan="1" colspan="1"><bold>Patient instructions</bold></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Fasting for at least 6 hours</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;No vasoactive medications for &#x0003e; 12
hours</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;No caffeine, cigarettes or nicotine for
&#x0003e; 12 hours</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;No physical exercise for &#x0003e; 6 hours</td></tr><tr style="border-bottom-width:thin;border-bottom-style:solid"><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Pre-menopausal women studied on day 1-7 of
menstrual cycle</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Pre data acquisition</bold></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Rest in supine position for at least 20
minutes (quiet and temperature-controlled room)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Blood pressure cuff positioned on forearm
or upper arm</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Brachial artery anatomical landmarks
identification for serial studies</td></tr><tr style="border-bottom-width:thin;border-bottom-style:solid"><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Linear array Doppler ultrasound machine
&#x0003e; 7.5 MHz</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Data acquisition</bold></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Ultrasound probe is positioned above the
antecubital fossa in the longitudinal plane</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Optimize image quality with clear
identification of lumen interface Insonation angle &#x02264;
60</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Baseline recording of diameter and velocity
for 1 minute pre cuff inflation</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Cuff inflation for 5 minutes at &#x02265; 50
mmHg above systolic pressure</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Record post-cuff release diameter and
hyperemia for 3 minutes</td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><p>Adapted from Anderson &#x00026; Phillips<sup>[<xref rid="r3" ref-type="bibr">3</xref>]</sup>.</p></fn></table-wrap-foot></table-wrap></sec></sec><sec><title>Microvascular Function</title><p>Regional blood flow is in large part controlled by tone in the smaller resistance
vessels. Dysfunction of these vessels can lead to ischemia, particularly in the
coronary circulation, as is the case in no-reflow or in chest pain syndromes and
minimal CAD, syndrome X or microvascular angina.</p><sec><title>Venous Occlusion Plethysmography</title><p>Prior to the introduction of the FMD technique, several groups reported on
the assessment of changes in forearm blood flow in response to the infusion
of intra-arterial vasoactive medications<sup>[<xref rid="r17" ref-type="bibr">17</xref>]</sup>. Plethysmography has been a technique to
measure blood flow for more than 100 years and is based on the premise of
measuring tissue (mainly muscle) blood flow reflected as a change in tissue
volume. The standard approach is to use a calibrated mercury-in-silastic
strain gauge placed around the forearm<sup>[<xref rid="r18" ref-type="bibr">18</xref>]</sup>. A BP cuff is used to isolate the hand and a
proximal cuff is inflated to 40 mmHg to prevent venous outflow. Arterial
inflow then results in expansion of the forearm with automated calibrated
systems allowing the calculation of forearm blood flow in mL/min/100 mL
tissue. Measurements are generally taken at rest and then after serial
direct intra-brachial infusions of escalating doses of endothelium-dependent
and independent agonists; Ach (or methacholine) and sodium nitroprusside
have been most commonly used. The contralateral arm is used as a control in
most laboratories. This provides important information about mechanisms
responsible for attenuated responses seen with CV risk factors. Most CV risk
factors have attenuated microvascular endothelial function<sup>[<xref rid="r19" ref-type="bibr">19</xref>]</sup>. Enzymatic inhibitors or
receptor antagonists such as NO synthase inhibitors or adrenergic blockers
can also be utilized.</p></sec></sec><sec><title>Reactive Hyperemia</title><p>Assessment of FMD typically involves the induction of a shear stress stimulus in
the conduit brachial artery following ischemia induced by occlusion of the
forearm vessels for 5 minutes. This shear stress is generated by dilation of the
microvasculature, thereby producing increased velocity and flow (reactive
hyperemia) in the conduit vessel. This can be measured by Doppler ultrasound
after the release of the BP cuff and expressed as either peak velocity, the
velocity time integral (VTI), forearm blood flow or systolic/diastolic ratio.
Huang et al.<sup>[<xref rid="r20" ref-type="bibr">20</xref>]</sup> demonstrated
that hyperemic velocity was related to adverse events in subjects with
peripheral vascular disease undergoing vascular surgery.</p><sec><title>Arterial Biopsy and Isolated Resistance Vessel Function</title><p>Microvascular dysfunction is an important contributor to increased
cardiometabolic risk. For example, impaired microvascular function can
contribute to reduced insulin sensitivity, increased total peripheral
resistance, and altered nutrient disposal<sup>[<xref rid="r21" ref-type="bibr">21</xref>]</sup>. In this context, studies of the
isolated, resistance arteries defined by their internal diameter (50-200
&#x000b5;m) can be made by dissecting arterioles from tissue biopsies. These
biopsies of the microcirculation have been made in the subcutaneous fat and
muscle<sup>[<xref rid="r22" ref-type="bibr">22</xref>]</sup>. In
addition, this technique to isolate arterioles from subcutaneous and
visceral fat<sup>[<xref rid="r23" ref-type="bibr">23</xref>]</sup>, coronary
arterioles discarded during surgery<sup>[<xref rid="r8" ref-type="bibr">8</xref>]</sup>. These preparations can involve the wire
myograph<sup>[<xref rid="r24" ref-type="bibr">24</xref>]</sup> or
the isolated perfused arterial preparation with measurements using a video
micrometer or an automated edge detector.</p></sec></sec></sec><sec><title>ARTERIAL FUNCTION AND CARDIOVASCULAR DISEASE MANAGEMENT</title><p>Although recent studies have played important roles in the diagnosis and prognosis of
endothelial assessment in individuals with CAD, there are several measures which are
able to evaluate the endothelial function (EF; see above)<sup>[<xref rid="r3" ref-type="bibr">3</xref>]</sup>. In this context, Chan et al.<sup>[<xref rid="r25" ref-type="bibr">25</xref>]</sup>, in 2003 evaluated EF by FMD and
endotheliumindependent dilations with 0.3 mg sublingually of nitroglycerin (NTG), in
152 CAD subjects. The results demonstrated that FMD and the FMD/NTG ratio were lower
in subjects with cardiac events. This result supports the concept that both
structural and functional properties of the vasculature are key co-determinants of
CVD outcomes. In addition, the authors concluded that the assessment of EF is a
predictor of future events, furthermore, the preserved carotid artery structure can
mitigate the risk of future events related platelet formation, and the endothelial
dysfunction reflects the propensity for atherosclerosis development in response to
previous, longstanding exposure to risk factors.</p><p>In a recent study, Sugamata et al.<sup>[<xref rid="r26" ref-type="bibr">26</xref>]</sup> assessed the EF in 923 CAD subjects, and were prospectively
followed up for &#x0003c;8.5 years or until a coronary event - cardiac death, non-fatal
myocardial infarction (MI) or unstable <italic>angina pectoris</italic> (uAP)
requiring unplanned coronary revascularization. During the follow-up period, 116
events occurred (29 cardiac deaths, 46 non-fatal MIs and 41 cases uAPs). The results
showed that FMD was independent predictor of secondary coronary events in patients
with CAD. These findings indicate that FMD may contribute to be useful for risk
stratification in patients with CAD.</p><p>In another study of patients with established CAD, Simova &#x00026; Denchev<sup>[<xref rid="r27" ref-type="bibr">27</xref>]</sup> showed similar results when
evaluated in 198 subjects admitted to a hospital with angina and multiple risk
factors divided into five groups according to the degree of CAD development. All
patients had FMD and intima-media thickness (IMT) measured, 105 (53.03%) performed a
treadmill test, and 146 (73.7%) underwent coronary arteriography (CAG). The results
demonstrated that the patients with significant (&#x02265; 50%) coronary artery
stenosis had lower FMD and higher IMT values compared to patients without
significant CAD. They concluded that endothelial evaluation presented important
acceptance prognostic in CAD patients.</p><p>Furthermore, Kuvin et al.<sup>[<xref rid="r28" ref-type="bibr">28</xref>]</sup>, in
2001 evaluated endothelium-dependent vasomotion (EDV) with FMD as a predictor of the
presence or absence of CAD as defined by exercise myocardial perfusion imaging
(ExMPI) in 94 CAD subjects. The results demonstrated that subjects with CAD (n=23)
had a lower FMD (6.3&#x000b1;0.7%) than those without CAD (10.5&#x000b1;0.6%). It was
concluded that endothelial evaluation is highly sensitive for coronary disease.</p><p>Nevertheless, studies demonstrating the FMD technique in other CV diseases may
indicate the diagnosis and prognosis role of this technique. Thereby, Wang et
al.<sup>[<xref rid="r29" ref-type="bibr">29</xref>]</sup> in 2009 in a
follow-up, assessed the EF by FMD in 101 patients with acute MI and ST-segment
elevation. The authors concluded that endothelial dysfunction significantly
increased the risk of vascular events against to abnormal EF as a sensitive
indicator of early development of atherosclerosis. In the same line of evidence, in
2010 Kazmierski et al.<sup>[<xref rid="r30" ref-type="bibr">30</xref>]</sup>
evaluated 75 men under 45 years of age, who were awaiting for elective coronary
angiography in the hospital. The subjects were divided into two groups: study group
(n=55) with obstructive coronary lesions and the control group (n=20) without
lesions. The authors demonstrated a significant reduction of FMD for the study group
when compared to control group (3.92&#x000b1;1.1 <italic>vs.</italic>
6.51&#x000b1;1.1). In this context, this finding demonstrated the relationship
between the FMD and CV risk factors, estimating which risk factors have significant
influence on EF. Additionally, these same authors investigated whether the
assessment of EF by FMD can be useful for assessing the risk of CV disease in
peri-menopausal women. The study involved 65 women with chest pain divided into a
study group (coronary lesions, n=32) and a control group (without lesions, n=33).
Atherosclerotic risk factors, early atherosclerotic remodeling by IMT and
endothelial dysfunction measured by FMD were analyzed in all subjects. The results
showed that IMT was significantly higher in the study group compared with controls
(0.059&#x000b1;0.01 <italic>vs.</italic> 0.049 &#x000b1;0.01 mm), moreover the FMD was
significantly lower in the study group compared with controls (6.53&#x000b1;0.98
<italic>vs.</italic> 7.89 &#x000b1;0.85). However, these results can be
influenced by the presence of hypercholesterolemia and all components of the
metabolic syndrome as well as by pharmacotherapy of these risk factors. The authors
concluded that FMD can be an important diagnostic tool to assess CV risk<sup>[<xref rid="r31" ref-type="bibr">31</xref>]</sup>.</p><p>Therefore, in this context, in a meta-analysis by Inaba et al.<sup>[<xref rid="r32" ref-type="bibr">32</xref>]</sup>, FMD is closely related to the
future of CV events, but further studies are needed to confirm the effectiveness of
the use of FMD in CV disease management. In this sense, a study by Patti et
al.<sup>[<xref rid="r33" ref-type="bibr">33</xref>]</sup>, evaluated the
recurrence of stenosis in 136 patients with single-vessel CAD undergoing
percutaneous coronary intervention (PCI) with stenting and at least 6 months of
follow-up. All patients underwent FMD 30 days after PCI; and nitroglycerin-FMD were
investigated before and after administration of sublingual NTG. The results showed
that clinical in-stent restenosis was demonstrated in 20 (15%) patients, whereas 116
(85%) patients remained free of signs or symptoms of recurrent ischemia. Also, FMD
was significantly impaired in patients with restenosis <italic>versus</italic> those
without restenosis. The authors concluded that early evaluation of endothelial
assessment may represent an important tool for predicting CV risk futures.</p><p>On the other hand, Frick et al.<sup>[<xref rid="r34" ref-type="bibr">34</xref>]</sup>
in 2005, assessed the prognostic value of FMD in a follow-up of 398 patients
admitted to hospital with chest pain. Patients were divided into two groups
according to the FMD median (7.6%), and after a mean follow-up of 39&#x000b1;12
months, CV events were documented. The results of the study demonstrated no
difference in the number of CV events between groups. The authors concluded that IMT
predicted late (up to 4 years) CV events, while the FMD technique is an important
prognostic tool for CV event predictor.</p><p>Muiesan et al.<sup>[<xref rid="r35" ref-type="bibr">35</xref>]</sup> evaluated 172
hypertension patients with the objective to evaluate the incidence of CV events
during follow-up an evaluation of EF in the brachial artery. The results
demonstrated that the CV events occurred in fewer patients with preserved FMD than
in those with impaired FMD 23 (27%) <italic>vs.</italic> 9 (10.5%), with an
incidence of 1.4 and 3.1 CV events per 100 patient-years. They concluded that
uncomplicated hypertensive patients, followed up for an average period of 8 years,
endothelial dysfunction, might identify patients at higher risk of CV events.</p><p>Considering others CV diseases, Meyer et al.<sup>[<xref rid="r36" ref-type="bibr">36</xref>]</sup> assessed 75 CHF patients with a left ventricular ejection
fraction (LVEF) &#x02264; 30%, which aimed to evaluate the predictive potency of
impaired endothelium dependent in this population. The results showed that FMD
significantly differed between event-free survivors or death in 75 CHF patients with
LVEF &#x02264; 30%, FMD values were significantly impaired in CHF patients who
reached the combined endpoint as compared with CHF survivors (5.4&#x000b1;5.1%
<italic>vs.</italic> 11.2&#x000b1;7.4%). These finding may be the result of the
impact of reduced EF in CHF. Therefore, reduced FMD may be an important tool for the
composite physiological and prognostic assessment of patients with CHF.</p></sec><sec><title>IMPACT OF EXERCISE PRESCRIPTION ON ARTERIAL FUNCTION</title><p>Physical exercise exerts beneficial effects on the human vascular system. Its acute
and chronic impact has been targeted by many investigators over time<sup>[<xref rid="r9" ref-type="bibr">9</xref>,<xref rid="r37" ref-type="bibr">37</xref>]</sup>. The mechanism by which exercise results in improvement of
arterial health is complex and is not fully understood. However, the effects of
exercise on arterial function may be in part related to improvements in the
endothelium function and health status.</p><p>Evidence suggests that exercise induces an up-regulation of endothelial NO synthase
(eNOS) gene expression and vascular endothelial growth factor (VEGF)-induced
angiogenesis; it also leads to a decrease in NO inactivation with augmented
availability of antioxidants, such as superoxide dismutase (SOD) and glutathione
peroxidase (GPx), and to an attenuation of nicotinamide adenine
dinucleotide/nicotinamide adenine dinucleotide phosphate (NADH/NADPH) oxidase
activity, leading to an increase in NO bioavailability<sup>[<xref rid="r9" ref-type="bibr">9</xref>,<xref rid="r37" ref-type="bibr">37</xref>,<xref rid="r38" ref-type="bibr">38</xref>]</sup>.</p><p>The shear stress effect on eNOS expression after exercise training was experimentally
observed in animal models and in human studies<sup>[<xref rid="r39" ref-type="bibr">39</xref>]</sup>. Hambrecht et al.<sup>[<xref rid="r40" ref-type="bibr">40</xref>]</sup> observed that a 4 weeks regular exercise training induced
a 2-fold increase in eNOS mRNA expression and vascular protein content in stable CAD
patients, suggesting that endothelial function improved possibly due to augmented
eNOS phosphorylation. Maiorana et al.<sup>[<xref rid="r41" ref-type="bibr">41</xref>]</sup>, assessed conduit vessel endothelial function in diabetic
patients using FMD of the brachial artery and demonstrated that 8 weeks of circuit
training did not affect vascular function in healthy men. However, Clarkson et
al.<sup>[<xref rid="r42" ref-type="bibr">42</xref>]</sup> observed that FMD
was enhanced following a 10 weeks program of daily aerobic and anaerobic exercise
training in healthy young men. Other evidence from CAD patients showed that ET
increases coronary blood flow through direct actions on the vasculature that improve
endothelial function, enhancing coronary vasodilation<sup>[<xref rid="r43" ref-type="bibr">43</xref>]</sup> and that even short-term ET could begin to
reverse endothelial dysfunction in these patients, even though a longer duration is
needed to restore endothelial function<sup>[<xref rid="r44" ref-type="bibr">44</xref>]</sup>.</p><p>Siasos et al.<sup>[<xref rid="r45" ref-type="bibr">45</xref>]</sup> investigated the
effects of continuous moderate and high intensity interval aerobic exercise on
endothelial function and arterial stiffness in healthy subjects and demonstrated
that both have favorable effects, suggesting a cardioprotective effect of both
intensities of exercise. However, in another study, Franklin et al.<sup>[<xref rid="r46" ref-type="bibr">46</xref>]</sup> showed that acute physical stress
induced by resistance exercise reduces FMD in sedentary obese women, suggesting that
this response to acute physical exertion may be an important marker for CV risk
prediction in this population.</p><p>A wealth of studies has been published whose results support the beneficial effects
of exercise training on arterial function. Evidence from subjects with endothelial
dysfunction confirms that exercise training improves vasodilator function of
resistance or conduit arteries<sup>[<xref rid="r44" ref-type="bibr">44</xref>]</sup>. However, findings from investigations on healthy asymptomatic
subjects with presumably normal endothelial function are less consistent<sup>[<xref rid="r47" ref-type="bibr">47</xref>]</sup>. The acute effects of exercise on
endothelium have been studied, but the number of studies is scarce and results are
controversial. Another important aspect to be considered is that different exercise
modalities are associated with different patterns of blood flow and arterial shear
stress which may somehow impact on responses and adaptation of arterial
function<sup>[<xref rid="r9" ref-type="bibr">9</xref>]</sup>. Besides,
physiological adaptation may depend on exercise intensity, duration and frequency.
Therefore, future studies to investigate the optimum exercise prescription in terms
of modes, intensities and volume are needed. <xref ref-type="table" rid="t2">Table
2</xref> summarizes the main exercise training programs studies assessing change
in FMD CAD patients.</p><table-wrap id="t2" orientation="portrait" position="float"><label>Table 2</label><caption><p>Summary of exercise training studies assessing change in FMD in coronary
arterial disease patients.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="20%" span="1"/><col width="20%" span="1"/><col width="20%" span="1"/><col width="20%" span="1"/><col width="20%" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Study</th><th align="center" rowspan="1" colspan="1">Cohort</th><th align="center" rowspan="1" colspan="1">Study design</th><th align="center" rowspan="1" colspan="1">Exercise training</th><th align="center" rowspan="1" colspan="1">Outcome(s)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Van Craenenbroeck et al.<sup>[<xref rid="r60" ref-type="bibr">60</xref>]</sup></td><td align="center" rowspan="1" colspan="1">Stable CAD</td><td align="center" rowspan="1" colspan="1">200 CAD randomized into 2 groups</td><td align="center" rowspan="1" colspan="1">12-wk of AIT vs. ACT on a bicycle, 3 times a
week</td><td align="center" rowspan="1" colspan="1">Both training changed FMD% and peak
VO<sub>2</sub></td></tr><tr><td align="left" rowspan="1" colspan="1">Kim et al.<sup>[<xref rid="r59" ref-type="bibr">59</xref>]</sup></td><td align="center" rowspan="1" colspan="1">Patients who received PCI due to ACS</td><td align="center" rowspan="1" colspan="1">32 nonrandomly divided into control (n=16) or CR
(n=16) group</td><td align="center" rowspan="1" colspan="1">6-wk of 50-minute ACT, 3 times a week</td><td align="center" rowspan="1" colspan="1">peak VO<sub>2</sub> and FMD (% and change) only for
CR group</td></tr><tr><td align="left" rowspan="1" colspan="1">Currie et al.<sup>[<xref rid="r61" ref-type="bibr">61</xref>]</sup></td><td align="center" rowspan="1" colspan="1">Stable CAD</td><td align="center" rowspan="1" colspan="1">22 CAD patients randomized into HIT (n=11) or ACT
(n=11) based on pretraining FMD</td><td align="center" rowspan="1" colspan="1">12-wk of ACT (30-50 min of cycling at 58%WR vs. HIT
(10 1-min intervals at 89% separated by 1-min intervals at 10%
WR)</td><td align="center" rowspan="1" colspan="1">Both training changed FMD% and peak
VO<sub>2</sub></td></tr><tr><td align="left" rowspan="1" colspan="1">Luk et al.<sup>[<xref rid="r58" ref-type="bibr">58</xref>]</sup></td><td align="center" rowspan="1" colspan="1">Stable CAD</td><td align="center" rowspan="1" colspan="1">64 randomized into control (32) and exercise training
program</td><td align="center" rowspan="1" colspan="1">8-wk of ACT program</td><td align="center" rowspan="1" colspan="1">FMD (1.84%) and exercise capacity (2 METS) only in
ACT group</td></tr><tr><td align="left" rowspan="1" colspan="1">Walsh et al.<sup>[<xref rid="r62" ref-type="bibr">62</xref>]</sup></td><td align="center" rowspan="1" colspan="1">Stable CAD</td><td align="center" rowspan="1" colspan="1">20 CAD patients randomized in 2 groups (trained vs.
controls)</td><td align="center" rowspan="1" colspan="1">8 wk of combined aerobic (70% MHR) + resistance
circuit training (55-65% MR)</td><td align="center" rowspan="1" colspan="1">&#x000a0;FMD (%) and glyceryl trinitrate GTN-mediated
dilation only in trained group</td></tr></tbody></table><table-wrap-foot><fn id="TFN2"><p>ACT=aerobic continuous training; ACS=acute coronary syndrome; AIT=aerobic
interval training; CAD=coronary arterial disease; CR=cardiac
rehabilitation; GTN=glyceryl trinitrate; HIT=high intensity training;
MET=metabolic equivalent; MHR=maximal heart rate; MR=maximal repetition;
PCI=percutaneous coronary intervention; VO<sub>2</sub>=oxygen uptake;
WR=work rate.</p></fn></table-wrap-foot></table-wrap></sec><sec><title>EXERCISE, ARTERIAL FUNCTION AND CARDIAC REHABILITATION</title><p>Exercise-based cardiac rehabilitation (CR) is widely recognized as a
non-pharmacological adjunct able to reduce all-cause and cardiac mortality and the
incidence of acute cardiac events, to modify risk factors associated with CVD and to
mitigate CV disease progression<sup>[<xref rid="r37" ref-type="bibr">37</xref>]</sup>. Exercise training positive effects on CV risk exposure are
partially due to its direct effects on the vessel wall<sup>[<xref rid="r48" ref-type="bibr">48</xref>]</sup>. Exercise induces increases in blood flow and
shear stress, which are recognized as important physiological stimuli for arterial
function improvement<sup>[<xref rid="r37" ref-type="bibr">37</xref>]</sup>.</p><p>Long-term vasculature adaptations determined by physical exercise result in an
improvement of systemic arterial vascular function not just in healthy individuals,
but also in patients affected by CVD. Arterial health can be compromised in various
pathological conditions affecting the cardiovascular system and in the presence of
CVD risk factors. Evidence shows that exercise is beneficial for patients suffering
from a variety of chronic diseases, including hypertension (HTN), coronary heart
disease (CHD), heart failure (HF) (reviewed above), obesity and insulin
resistance<sup>[<xref rid="r9" ref-type="bibr">9</xref>]</sup>.</p><p>Higashi et al.<sup>[<xref rid="r38" ref-type="bibr">38</xref>]</sup> investigated FMD
in HTN subjects and showed that moderate intensity aerobic exercise significantly
improved endothelial health in this population. Collier et al.<sup>[<xref rid="r49" ref-type="bibr">49</xref>]</sup> showed that arterial function was
improved in HTN patients following 4 weeks of either aerobic or resistance training.
Most of the studies that investigated ET effects on endothelial function reported
correlations with improved insulin sensitivity and other insulin mediated metabolic
functions<sup>[<xref rid="r9" ref-type="bibr">9</xref>]</sup>. Hambrecht et
al.<sup>[<xref rid="r44" ref-type="bibr">44</xref>]</sup> studied the
cardioprotective effects of ET in CAD patients and showed that 4 weeks of ET on a
cycle ergometer improved endothelium-dependent vasodilation both in epicardial
coronary vessels and in resistance vessels.</p><p>Collectively, evidence suggests that arterial function is amenable to improvement in
subjects at known or increased cardiovascular disease risk who undertake physical
exercise training. In the sections that follow, we will present existing evidence
related to how exercise training can be applied for primary and secondary CVD
prevention.</p><sec><title>a. Primary Prevention</title><p>Evidence suggests that lifestyle modification via regular exercise has
significant preventive effects against CVD by reducing multiple risk factors; on
the other hand, physical inactivity is largely associated with CVD development.
One of the factors that contribute to the genesis of CVD<sup>[<xref rid="r37" ref-type="bibr">37</xref>]</sup>.</p><p>Impaired endothelium-dependent vasodilation appears to be the earliest event of
atherosclerosis and is therefore considered the focus of strategies for CVD
prevention. Moreover, endothelial dysfunction has been extensively associated
with most of the established CV risk factors (<italic>e.g</italic>.
dyslipidaemia, hypertension, smoking, and diabetes mellitus). Experimental
findings demonstrate that exercise training is able to prevent and improve
endothelial dysfunction. Furthermore, management of CV risk factors also tends
to improve or restore endothelial function<sup>[<xref rid="r9" ref-type="bibr">9</xref>,<xref rid="r50" ref-type="bibr">50</xref>]</sup>.</p><p>Jacomini et al.<sup>[<xref rid="r51" ref-type="bibr">51</xref>]</sup> studied the
influence of the training status on blood pressure in older women and showed
that better performance in a Fitness Battery Test and higher maximal oxygen
uptake were related to lower levels of oxidative stress and protein damage.
Moreover, the authors observed that a better training status is related to a
higher concentration of nitrite and nitrate, a decrease of which was shown to be
correlated with increasing numbers of CV risk factors and endothelial
dysfunction.</p><p>Regular aerobic exercise was also associated with improvements in conduit artery
and microvessel FMD, following an acute strenuous physical exertion in
overweight and obese individuals. Since acute stress to the vascular endothelium
is linked to higher incidence of CVD, physical exercise practice appears to be
fundamental to protect against vascular dysfunction<sup>[<xref rid="r50" ref-type="bibr">50</xref>]</sup>.</p><p>The acute effects of continuous moderate intensity aerobic exercise (CAE) and
high intensity interval aerobic exercise (HIAE) on endothelial function and
arterial stiffness were investigated by Siasos et al.<sup>[<xref rid="r45" ref-type="bibr">45</xref>]</sup> in healthy individuals. Participants
performed an isocaloric protocol on a cycle ergometer and presented
significantly improved FMD after both protocols. The authors suggested a
cardioprotective effect of exercise on the progression of atherosclerosis.</p></sec><sec><title>b. Secondary Prevention</title><p>It is clearly recognized that physical inactivity is related to increased risk
for morbidity and mortality and contributes to health care costs, particularly
in patients with CVD<sup>[<xref rid="r52" ref-type="bibr">52</xref>]</sup>.
Therefore, Schmidt et al.<sup>[<xref rid="r53" ref-type="bibr">53</xref>]</sup>
have recently focused on evaluating the mechanisms responsible for the systemic
effects of physical exercise on secondary CV prevention.</p><p>The potential beneficial effects of exercise are multifaceted. In the context of
vascular function, physical exercise induces upregulation of eNOS expression and
activity, which has been associated to consequent endothelium-dependent
vasodilatation<sup>[<xref rid="r54" ref-type="bibr">54</xref>]</sup>.
This phenomenon is linked to consequent peripheral neovascularization including
arterial function and angiogenesis. In addition, the vascular system is expanded
in size and number of microvessels in patients with CAD<sup>[<xref rid="r55" ref-type="bibr">55</xref>]</sup>.</p><p>Attention has focused on noninvasive tools to measure of arterial function in CAD
patients. Based on the ability of the endothelium to acutely dilate in response
to an increase in blood flow, the FMD has been constituted as an important index
of endothelial function predictive of future CV events in chronic arterial
disease<sup>[<xref rid="r56" ref-type="bibr">56</xref>]</sup>. In
addition, impaired endothelial function has been shown to limit exercise
performance in CAD patients<sup>[<xref rid="r57" ref-type="bibr">57</xref>]</sup>, even as a lower level of habitual PAL is associated with
impaired FMD in these patients<sup>[<xref rid="r58" ref-type="bibr">58</xref>]</sup>. FMD also have demonstrated to be a reproducible
measurement for short- and medium-term assessment of pharmacological and
nonpharmacological interventions, such as exercise training. However, different
modalities of physical training program, training intensity duration, as well as
volume of exercise training, can influence on endothelial function responses in
coronary disease patients.</p><p>For instance, Kin et al.<sup>[<xref rid="r59" ref-type="bibr">59</xref>]</sup>
applied a protocol based on six-week and three times a week of aerobic exercise
training program in a group of patients who were hospitalized due to acute
coronary syndrome. The intensity of exercise training program consisted of
40%-85% of the heart rate reserve and the total duration were 30 minutes,
intercalating rest periods with exercise on a cycle and treadmill. They observed
a significant improvement of FMD change after 6 weeks, however, a none
significant difference was observed when compared to controls. However, 12 weeks
of both aerobic interval training and continuous exercise training on cycle
could significantly improve aerobic capacity (as expressed by VO<sub>2</sub>
peak), markers of endothelial integrity and FMD percentage in a large population
of CAD patients<sup>[<xref rid="r60" ref-type="bibr">60</xref>]</sup>.</p><p>On the other hand, Currie et al.<sup>[<xref rid="r61" ref-type="bibr">61</xref>]</sup> contrasted 12 week of low-volume high-intensity interval
exercise training <italic>versus</italic> higher volume, moderate intensity
endurance exercise. Both training program significantly increased relative FMD
post training in a similar way, with no differences between groups. These
results taken together show that longer protocols (12 weeks) seem to demonstrate
better responses, and that, in addition, continuous or interval training may be
both important training strategies to improve endothelial function in patients
with CAD. In addition, Walsh et al.<sup>[<xref rid="r62" ref-type="bibr">62</xref>]</sup> tested the effects of resistance associated to aerobic
exercise training program was applied during 8 weeks, three times a week. The
authors observed that combined exercise training improved FMD percentage, but
not the responsiveness of endothelium-independent vasodilation, measured by
administration of glyceryl trinitrate.</p><p>Although there is already a certain body of knowledge about the potential
beneficial effects of physical exercise on endothelial function in patients with
CAD, there is still a need for future studies to evaluate long-term effects of
physical training in these patients. In addition, there is still no evidence for
the effects of high versus low continuous intensity training, as well as the
effects of resistance training and strength training in these patients. Thus,
new studies in order to evaluate these existing gaps still become necessary in
future studies.</p></sec><sec><title>c. Peripheral Arterial Disease</title><p>Peripheral arterial disease (PAD) affects eight million men and women in the USA,
however, in Brazil, data related to the prevalence of PAD and its risk factors
are scarce and restricted to specific populations. Endothelial function is
impaired in individuals with PAD compared to individuals without PAD<sup>[<xref rid="r63" ref-type="bibr">63</xref>]</sup>. On the other hand, higher
levels of physical activity during daily life are associated significantly and
independently with better brachial artery FMD among individuals with PAD.</p><p>In this context, Januszek et al.<sup>[<xref rid="r64" ref-type="bibr">64</xref>]</sup> showed that 12 weeks of supervised, intermittent treadmill
walking until induce claudication, three times a week, prolonged the
asymptomatic walking distance and improved brachial artery FMD in 43% after
program. Another study that tested the hypothesis of potential effects of
endothelial function in PAD patients that underwent to a supervised treadmill
training program of 12 weeks found that brachial artery FMD values increased by
45% after program and the patients with better walking abilities at baseline
derived greater clinical and metabolic benefits<sup>[<xref rid="r65" ref-type="bibr">65</xref>]</sup>. However, a recent meta-analysis study
observed that exercise training, compared with medical care, significantly
improved cardiorespiratory fitness, pain-free and total flat-ground walking
distances, as well as graded treadmill performance in PAD, but not
ankle-brachial index and FMD in PAD patients<sup>[<xref rid="r66" ref-type="bibr">66</xref>]</sup>.</p><p>In conclusion, to date, the effects of resistance and strength training on FMD in
PAD patients. New studies with the objective of testing the potential effects of
resistance exercise protocols can be conducted in the future.</p></sec></sec><sec><title>ARTERIAL FUNCTION, REHABILITATION AND STROKE</title><p>Considering that endothelial dysfunction plays a role in the development and
progression of atherosclerosis, ischemic stroke is also strongly associated with
endothelial dysfunction. In fact, patients with acute ischemic stroke have impaired
FMD in comparison with control subjects, FMD is negatively related to stroke
severity, and impaired FMD is also associated with poor outcome in these
patients<sup>[<xref rid="r67" ref-type="bibr">67</xref>]</sup>. In addition,
FMD &#x02264; 4.5% was an independent predictor of a new-onset vascular event after
stroke, with lower event-free survival rates within 48 months after a first ischemic
stroke<sup>[<xref rid="r68" ref-type="bibr">68</xref>]</sup>.</p><p>It is well established that physical activity, as a modifiable risk factor, has
beneficial effects on cardiovascular health<sup>[<xref rid="r37" ref-type="bibr">37</xref>]</sup>. Improvement on endothelial function and
neovascularization related to regular exercise training contribute to these results,
therefore, it is reasonable to predict the importance of exercise on prevention of
cerebrovascular disease<sup>[<xref rid="r53" ref-type="bibr">53</xref>]</sup>. The
Cardiovascular Health Study found that greater levels of physical activity were
associated to lower incidence of stroke in a population of 4207 US men and women
with age &#x02265; 65 years followed for 10 years<sup>[<xref rid="r69" ref-type="bibr">69</xref>]</sup>. The Women's Health Study also demonstrated that
leisure time physical activity was associated to lower stroke risk in healthy women
&#x02265; 45 years followed for 11.9 years, in average<sup>[<xref rid="r70" ref-type="bibr">70</xref>]</sup>.</p><p>There are few studies related to endothelial function after rehabilitation in stroke
patients. Billinger et al.<sup>[<xref rid="r71" ref-type="bibr">71</xref>]</sup>
applied 8 weeks of aerobic exercise three times per week in 9 subacute stroke
patients. They evaluated brachial artery FMD in both arms (stroke-affected and
non-affected limbs) at baseline, postintervention and 1 month follow-up. The authors
found lower FMD in the affected arm at baseline and at post-intervention
measurements, with improvement on vascular health after treatment with sustained
improvement on follow-up. Takatori et al.<sup>[<xref rid="r72" ref-type="bibr">72</xref>]</sup> performed a randomized controlled study investigating the
effects of intensive rehabilitation for 12 weeks, twice a week, on physical and
arterial function of chronic stroke survivors patients. The authors found a
significant improvement on arterial function (cardio-ankle vascular index and
ankle-brachial pressure index) after the rehabilitation period on experimental group
in comparison with control group, despite of no changes on physical function.</p></sec><sec><title>ARTERIAL FUNCTION AND CARDIOVASCULAR SURGERY</title><p>The diagnostic value of microvascular and conduit artery endothelial dysfunction has
increasingly been investigated in the cardiovascular population<sup>[<xref rid="r73" ref-type="bibr">73</xref>]</sup>. Flow-mediated dilation,
quantified by noninvasive methods such as brachial artery reactivity testing (BART),
is impaired in patients with CAD<sup>[<xref rid="r73" ref-type="bibr">73</xref>]</sup>, providing improved sensitivity and negative predictive value
for the diagnosis of CAD. Cardiovascular risk factors predispose to perioperative
morbidity and mortality, with evidence that patients with microvascular dysfunction
undergoing cardiovascular interventions are at increased risk for postoperative
complications<sup>[<xref rid="r73" ref-type="bibr">73</xref>]</sup>.</p><p>In this context, Patti et al.<sup>[<xref rid="r33" ref-type="bibr">33</xref>]</sup>
included in a prospective study 136 patients with single-vessel CAD undergoing
percutaneous coronary intervention (PCI) with stenting and at least 6 months of
follow-up. The authors verified whether early measurement of brachial artery FMD
after coronary stenting could predict occurrence of in-stent restenosis. All
patients underwent ultrasound detection of brachial artery reactivity 30 days after
PCI. FMD was significantly impaired in patients with restenosis versus those without
restenosis (percent diameter variation 4.6 &#x000b1; 5.8% <italic>versus</italic> 9.5
&#x000b1; 6.6%, <italic>P</italic>=0.002); moreover, 4% of patients with FMD &#x02265;
7% (median value) developed in-stent restenosis <italic>versus</italic> 28% of those
with FMD &#x0003c; 7% (<italic>P</italic>=0.0001). The results this study indicating that
impaired FMD independently predicts occurrence of in-stent restenosis in patients
undergoing PCI and may represent a useful screening tool to stratify patients
according to future risk of restenosis.</p><p>Cardiopulmonary bypass (CPB) exerts several deleterious effects in patients
undergoing myocardial revascularization, including inflammatory pathways. Most of
these can be related to an endothelial insult leading to endothelial dysfunction.
Sangalli et al.<sup>[<xref rid="r74" ref-type="bibr">74</xref>]</sup> using FMD of
the brachial artery assessed 29 patients undergoing elective myocardial
revascularization. Ten patients receiving continuous-flow CPB, 10 receiving
pulsatile-flow CPB, and 9 scheduled for beating-heart revascularization were
studied. Patients were studied at baseline (after induction of general anesthesia),
after CPB upon intensive care unit (ICU) admission after surgery, and on the first
postoperative day before discharge from the ICU (on average, 24 hours after CPB
discontinuation). The continuous-flow CPB group demonstrated a significant reduction
in FMD after CPB (12.8&#x000b1;9.7% <italic>vs.</italic> 1.6&#x000b1;1.5%,
<italic>P</italic>&#x0003c;0.01), which lasted up to the first postoperative day
(5.9%&#x000b1;4.1%). On the other hand, FMD did not change in the pulsatile-flow
group (12.5&#x000b1;10.5%, 11.0&#x000b1;7.2%, and 16.6&#x000b1;11.7%, respectively).
FMD also was unaffected in the beating-heart group, thus suggesting a direct effect
of CPB itself on endothelial function. In conclusion, in these patients,
continuous-flow CPB markedly impaired endothelial function, although this was not
the case with pulsatile-flow CPB group.</p><p>Gokce et al.<sup>[<xref rid="r75" ref-type="bibr">75</xref>]</sup> preoperatively
examined brachial artery vasodilation using ultrasound in 187 patients undergoing a
vascular operation, including carotid endarterectomy (47 patients),
femoral-popliteal or other peripheral bypass (100 patients), aortic aneurysm repair
(24 patients), and limb amputation (16 patients). Patients were prospectively
followed for 30 days after surgery. Forty-five patients had a postoperative event,
including cardiac death (3), myocardial infarction (12), unstable angina/ischemic
ventricular fibrillation (2), stroke (3), or elevated troponin I, reflecting
myocardial necrosis (25). Preoperative endothelium dependent FMD was significantly
lower in patients with an event (4.9&#x000b1;3.1%) than in those without an event
(7.3&#x000b1;5%; <italic>P</italic>=0.001), whereas endothelium-independent
vasodilation to nitroglycerin was similar in both groups. In a Cox
proportional-hazards model, the independent predictors of events were age
(<italic>P</italic>=0.001), renal insufficiency (<italic>P</italic>=0.03),
non-carotid surgery (<italic>P</italic>=0.05), and lower brachial artery FMD
(<italic>P</italic>=0.007). In this study, impaired brachial artery endothelial
function was independently predicts postoperative cardiac events, which supports a
role for endothelial dysfunction in the pathogenesis of cardiovascular disease.</p><p>The primary endpoint of this study, Schier et al.<sup>[<xref rid="r76" ref-type="bibr">76</xref>]</sup> investigated whether preoperative BART-derived
variables would predict postoperative complications, not restricted to
cardiovascular events but inclusive of all postoperative complications that commonly
occur after major thoracic surgery. The authors investigated 63 patients using
BART-derived variables, including FMD, in preoperative risk stratification for major
thoracic surgery. Patients in the low FMD group experienced more postoperative
complications when compared high FMD: 54% <italic>versus</italic> 30% had one or
more adverse postoperative event, and 11% <italic>versus</italic> 0 had three or
more adverse postoperative events (<italic>P</italic>&#x0003c;0.001), respectively. The
authors concluded that preoperative microvascular dysfunction can be identified in
patients at increased risk for postoperative complications.</p></sec><sec sec-type="conclusions"><title>CONCLUSION</title><p>The understanding of the vascular regulation of blood flow and perfusion in the
peripheral circulation has grown dramatically in the past 3 decades. The endothelium
plays a crucial role in regulating blood vessel function and is an important
prognostic indicator of arterial function and cardiovascular risk. Alterations in
arterial function are critical in the pathogenesis of cardiovascular disease
including the risk factors that lead up to overt CAD and CV surgery. In addition,
rehabilitation strategies in the context of primary and secondary prevention for CV
disease (hypertension, obesity, stroke, MI) and following surgery have important
positive impacts on nitric oxide and hence conduit artery endothelial function.
Future focus should remain on the optimal mode and intensity of such rehabilitation
strategies for the benefit of endothelial function and lowering CV risk and
disease.</p><table-wrap id="t4" orientation="portrait" position="anchor"><table frame="hsides" rules="groups"><colgroup span="1"><col width="10%" span="1"/><col width="90%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" rowspan="1">Authors' roles &#x00026; responsibilities</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">SAP</td><td align="left" rowspan="1" colspan="1">Conception and design study; manuscript redaction or
<break/>critical review of its content; final manuscript
approval</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">DKA</td><td align="left" rowspan="1" colspan="1">Conception and design study; manuscript redaction or
<break/>critical review of its content; final manuscript
approval</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">RGM</td><td align="left" rowspan="1" colspan="1">Conception and design study; manuscript redaction or
<break/>critical review of its content; final manuscript
approval</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">FRC</td><td align="left" rowspan="1" colspan="1">Conception and design study; manuscript redaction or
<break/>critical review of its content; final manuscript
approval</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">RC</td><td align="left" rowspan="1" colspan="1">Conception and design study; manuscript redaction or
<break/>critical review of its content; final manuscript
approval</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">RBJ</td><td align="left" rowspan="1" colspan="1">Conception and design study; manuscript redaction or
<break/>critical review of its content; final manuscript
approval</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">RA</td><td align="left" rowspan="1" colspan="1">Conception and design study; manuscript redaction or
<break/>critical review of its content; final manuscript
approval</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">ABS</td><td align="left" rowspan="1" colspan="1">Conception and design study; manuscript redaction or
<break/>critical review of its content; final manuscript
approval</td></tr></tbody></table></table-wrap></sec></body><back><fn-group><fn fn-type="COI-statement"><p>No conflict of interest.</p></fn><fn fn-type="other"><p>This study was carried out at the Department of Physical Therapy, Integrative
Physiology Laboratory, College of Applied Health Sciences, University of
Illinois at Chicago, Chicago, IL, USA.</p></fn><fn fn-type="supported-by"><p>No financial support.</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="r1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rocha-e-Silva</surname><given-names>M</given-names></name></person-group><article-title>Cardiovascular effects of shock and trauma in experimental
models. A review</article-title><source>Braz J Cardiovasc Surg</source><year>2016</year><volume>31</volume><issue>1</issue><fpage>45</fpage><lpage>51</lpage><pub-id pub-id-type="pmid">27074274</pub-id></element-citation></ref><ref id="r2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Landmesser</surname><given-names>U</given-names></name><name><surname>Hornig</surname><given-names>B</given-names></name><name><surname>Drexler</surname><given-names>H</given-names></name></person-group><article-title>Endothelial function: a critical determinant in
atherosclerosis?</article-title><source>Circulation</source><year>2004</year><volume>109</volume><issue>21 Suppl 1</issue><fpage>II27</fpage><lpage>II33</lpage><pub-id pub-id-type="pmid">15173060</pub-id></element-citation></ref><ref id="r3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anderson</surname><given-names>TJ</given-names></name><name><surname>Phillips</surname><given-names>SA</given-names></name></person-group><article-title>Assessment and prognosis of peripheral artery measures of
vascular function</article-title><source>Prog Cardiovasc Dis</source><year>2015</year><volume>57</volume><issue>5</issue><fpage>497</fpage><lpage>509</lpage><pub-id pub-id-type="pmid">25460848</pub-id></element-citation></ref><ref id="r4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dharmashankar</surname><given-names>K</given-names></name><name><surname>Welsh</surname><given-names>A</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Kizhakekuttu</surname><given-names>TJ</given-names></name><name><surname>Ying</surname><given-names>R</given-names></name><name><surname>Gutterman</surname><given-names>DD</given-names></name><etal/></person-group><article-title>Nitric oxide synthase-dependent vasodilation of human
subcutaneous arterioles correlates with noninvasive measurements of
endothelial function</article-title><source>Am J Hypertens</source><year>2012</year><volume>25</volume><issue>5</issue><fpage>528</fpage><lpage>534</lpage><pub-id pub-id-type="pmid">22337207</pub-id></element-citation></ref><ref id="r5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koller</surname><given-names>A</given-names></name><name><surname>Sun</surname><given-names>D</given-names></name><name><surname>Huang</surname><given-names>A</given-names></name><name><surname>Kaley</surname><given-names>G</given-names></name></person-group><article-title>Corelease of nitric oxide and prostaglandins mediates
flow-dependent dilation of rat gracilis muscle arterioles</article-title><source>Am J Physiol</source><year>1994</year><volume>267</volume><issue>1</issue><issue-part>Pt 2</issue-part><fpage>H326</fpage><lpage>H332</lpage><pub-id pub-id-type="pmid">8048598</pub-id></element-citation></ref><ref id="r6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Phillips</surname><given-names>SA</given-names></name><name><surname>Hatoum</surname><given-names>OA</given-names></name><name><surname>Gutterman</surname><given-names>DD</given-names></name></person-group><article-title>The mechanism of flow-induced dilation in human adipose
arterioles involves hydrogen peroxide during CAD</article-title><source>Am J Physiol Heart Circ Physiol</source><year>2007</year><volume>292</volume><issue>1</issue><fpage>H93</fpage><lpage>100</lpage><pub-id pub-id-type="pmid">17040967</pub-id></element-citation></ref><ref id="r7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Celermajer</surname><given-names>DS</given-names></name><name><surname>Sorensen</surname><given-names>KE</given-names></name><name><surname>Bull</surname><given-names>C</given-names></name><name><surname>Robinson</surname><given-names>J</given-names></name><name><surname>Deanfield</surname><given-names>JE</given-names></name></person-group><article-title>Endothelium-dependent dilation in the systemic arteries of
asymptomatic subjects relates to coronary risk factors and their
interaction</article-title><source>J Am Coll Cardiol</source><year>1994</year><volume>24</volume><issue>6</issue><fpage>1468</fpage><lpage>1474</lpage><pub-id pub-id-type="pmid">7930277</pub-id></element-citation></ref><ref id="r8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Terata</surname><given-names>K</given-names></name><name><surname>Miura</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Loberiza</surname><given-names>F</given-names></name><name><surname>Gutterman</surname><given-names>DD</given-names></name></person-group><article-title>Human coronary arteriolar dilation to adrenomedullin: role of
nitric oxide and K(+) channels</article-title><source>Am J Physiol Heart Circ Physiol</source><year>2000</year><volume>279</volume><issue>6</issue><fpage>H2620</fpage><lpage>H2626</lpage><pub-id pub-id-type="pmid">11087213</pub-id></element-citation></ref><ref id="r9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Phillips</surname><given-names>SA</given-names></name><name><surname>Mahmoud</surname><given-names>AM</given-names></name><name><surname>Brown</surname><given-names>MD</given-names></name><name><surname>Haus</surname><given-names>JM</given-names></name></person-group><article-title>Exercise interventions and peripheral arterial function:
implications for cardio-metabolic disease</article-title><source>Prog Cardiovasc Dis</source><year>2015</year><volume>57</volume><issue>5</issue><fpage>521</fpage><lpage>534</lpage><pub-id pub-id-type="pmid">25529367</pub-id></element-citation></ref><ref id="r10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anderson</surname><given-names>TJ</given-names></name><name><surname>Uehata</surname><given-names>A</given-names></name><name><surname>Gerhard</surname><given-names>MD</given-names></name><name><surname>Meredith</surname><given-names>IT</given-names></name><name><surname>Knab</surname><given-names>S</given-names></name><name><surname>Delagrange</surname><given-names>D</given-names></name><etal/></person-group><article-title>Close relation of endothelial function in the human coronary and
peripheral circulations</article-title><source>J Am Coll Cardiol</source><year>1995</year><volume>26</volume><issue>5</issue><fpage>1235</fpage><lpage>1241</lpage><pub-id pub-id-type="pmid">7594037</pub-id></element-citation></ref><ref id="r11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anderson</surname><given-names>TJ</given-names></name><name><surname>Meredith</surname><given-names>IT</given-names></name><name><surname>Yeung</surname><given-names>AC</given-names></name><name><surname>Frei</surname><given-names>B</given-names></name><name><surname>Selwyn</surname><given-names>AP</given-names></name><name><surname>Ganz</surname><given-names>P</given-names></name></person-group><article-title>The effect of cholesterol-lowering and antioxidant therapy on
endotheliumdependent coronary vasomotion</article-title><source>N Engl J Med</source><year>1995</year><volume>332</volume><issue>8</issue><fpage>488</fpage><lpage>493</lpage><pub-id pub-id-type="pmid">7830729</pub-id></element-citation></ref><ref id="r12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Celermajer</surname><given-names>DS</given-names></name><name><surname>Sorensen</surname><given-names>KE</given-names></name><name><surname>Spiegelhalter</surname><given-names>DJ</given-names></name><name><surname>Georgakopoulos</surname><given-names>D</given-names></name><name><surname>Robinson</surname><given-names>J</given-names></name><name><surname>Deanfield</surname><given-names>JE</given-names></name></person-group><article-title>Aging is associated with endothelial dysfunction in healthy men
years before the age-related decline in women</article-title><source>J Am Coll Cardiol</source><year>1994</year><volume>24</volume><issue>2</issue><fpage>471</fpage><lpage>476</lpage><pub-id pub-id-type="pmid">8034885</pub-id></element-citation></ref><ref id="r13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Green</surname><given-names>DJ</given-names></name><name><surname>Dawson</surname><given-names>EA</given-names></name><name><surname>Groenewoud</surname><given-names>HM</given-names></name><name><surname>Jones</surname><given-names>H</given-names></name><name><surname>Thijssen</surname><given-names>DH</given-names></name></person-group><article-title>Is flowmediated dilation nitric oxide mediated? A
meta-analysis</article-title><source>Hypertension</source><year>2014</year><volume>63</volume><issue>2</issue><fpage>376</fpage><lpage>382</lpage><pub-id pub-id-type="pmid">24277765</pub-id></element-citation></ref><ref id="r14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joannides</surname><given-names>R</given-names></name><name><surname>Haefeli</surname><given-names>WE</given-names></name><name><surname>Linder</surname><given-names>L</given-names></name><name><surname>Richard</surname><given-names>V</given-names></name><name><surname>Bakkali</surname><given-names>EH</given-names></name><name><surname>Thuillez</surname><given-names>C</given-names></name><etal/></person-group><article-title>Nitric oxide is responsible for flow-dependent dilatation of
human peripheral conduit arteries in vivo</article-title><source>Circulation</source><year>1995</year><volume>91</volume><issue>5</issue><fpage>1314</fpage><lpage>1319</lpage><pub-id pub-id-type="pmid">7867167</pub-id></element-citation></ref><ref id="r15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yeboah</surname><given-names>J</given-names></name><name><surname>Crouse</surname><given-names>JR</given-names></name><name><surname>Hsu</surname><given-names>FC</given-names></name><name><surname>Burke</surname><given-names>GL</given-names></name><name><surname>Herrington</surname><given-names>DM</given-names></name></person-group><article-title>Brachial flowmediated dilation predicts incident cardiovascular
events in older adults: the Cardiovascular Health Study</article-title><source>Circulation</source><year>2007</year><volume>115</volume><issue>18</issue><fpage>2390</fpage><lpage>2397</lpage><pub-id pub-id-type="pmid">17452608</pub-id></element-citation></ref><ref id="r16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yeboah</surname><given-names>J</given-names></name><name><surname>Folsom</surname><given-names>AR</given-names></name><name><surname>Burke</surname><given-names>GL</given-names></name><name><surname>Johnson</surname><given-names>C</given-names></name><name><surname>Polak</surname><given-names>JF</given-names></name><name><surname>Post</surname><given-names>W</given-names></name><etal/></person-group><article-title>Predictive value of brachial flow-mediated dilation for incident
cardiovascular events in a population-based study: The multi-ethnic study of
atherosclerosis</article-title><source>Circulation</source><year>2009</year><volume>120</volume><issue>6</issue><fpage>502</fpage><lpage>509</lpage><pub-id pub-id-type="pmid">19635967</pub-id></element-citation></ref><ref id="r17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Panza</surname><given-names>JA</given-names></name><name><surname>Quyyumi</surname><given-names>AA</given-names></name><name><surname>Brush Jr</surname><given-names>JE</given-names></name><name><surname>Epstein</surname><given-names>SE</given-names></name></person-group><article-title>Abnormal endotheliumdependent vascular relaxation in patients
with essential hypertension</article-title><source>N Engl J Med</source><year>1990</year><volume>323</volume><issue>1</issue><fpage>22</fpage><lpage>27</lpage><pub-id pub-id-type="pmid">2355955</pub-id></element-citation></ref><ref id="r18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hokanson</surname><given-names>DE</given-names></name><name><surname>Sumner</surname><given-names>DS</given-names></name><name><surname>Strandness</surname><given-names>DE Jr</given-names></name></person-group><article-title>An electrically calibrated plethysmograph for direct measurement
of limb blood flow</article-title><source>IEEE Trans Biomed Eng</source><year>1975</year><volume>22</volume><issue>1</issue><fpage>25</fpage><lpage>29</lpage><pub-id pub-id-type="pmid">1110089</pub-id></element-citation></ref><ref id="r19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnstone</surname><given-names>MT</given-names></name><name><surname>Creager</surname><given-names>SJ</given-names></name><name><surname>Scales</surname><given-names>KM</given-names></name><name><surname>Cusco</surname><given-names>JA</given-names></name><name><surname>Lee</surname><given-names>BK</given-names></name><name><surname>Creager</surname><given-names>MA</given-names></name></person-group><article-title>Impaired endothelium-dependent vasodilation in patients with
insulindependent diabetes mellitus</article-title><source>Circulation</source><year>1993</year><volume>88</volume><issue>6</issue><fpage>2510</fpage><lpage>2516</lpage><pub-id pub-id-type="pmid">8080489</pub-id></element-citation></ref><ref id="r20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>AL</given-names></name><name><surname>Silver</surname><given-names>AE</given-names></name><name><surname>Shvenke</surname><given-names>E</given-names></name><name><surname>Schopfer</surname><given-names>DW</given-names></name><name><surname>Jahangir</surname><given-names>E</given-names></name><name><surname>Titas</surname><given-names>MA</given-names></name><etal/></person-group><article-title>Predictive value of reactive hyperemia for cardiovascular events
in patients with peripheral arterial disease undergoing vascular
surgery</article-title><source>Arterioscler Thromb Vasc Biol</source><year>2007</year><volume>27</volume><issue>10</issue><fpage>2113</fpage><lpage>2119</lpage><pub-id pub-id-type="pmid">17717291</pub-id></element-citation></ref><ref id="r21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jonk</surname><given-names>AM</given-names></name><name><surname>Houben</surname><given-names>AJ</given-names></name><name><surname>Jongh</surname><given-names>de RT</given-names></name><name><surname>Serne</surname><given-names>EH</given-names></name><name><surname>Schaper</surname><given-names>NC</given-names></name><name><surname>Stehouwer</surname><given-names>CD</given-names></name></person-group><article-title>Microvascular dysfunction in obesity: a potential mechanism in
the pathogenesis of obesity-associated insulin resistance and
hypertension</article-title><source>Physiology</source><year>2007</year><volume>22</volume><fpage>252</fpage><lpage>260</lpage><pub-id pub-id-type="pmid">17699878</pub-id></element-citation></ref><ref id="r22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mahmoud</surname><given-names>AM</given-names></name><name><surname>Szczurek</surname><given-names>MR</given-names></name><name><surname>Blackburn</surname><given-names>BK</given-names></name><name><surname>Mey</surname><given-names>JT</given-names></name><name><surname>Chen</surname><given-names>Z</given-names></name><name><surname>Robinson</surname><given-names>AT</given-names></name><etal/></person-group><article-title>Hyperinsulinemia augments endothelin-1 protein expression and
impairs vasodilation of human skeletal muscle arterioles</article-title><source>Physiol Rep</source><year>2016</year><volume>4</volume><issue>16</issue><elocation-id>e12895</elocation-id><pub-id pub-id-type="pmid">27796268</pub-id></element-citation></ref><ref id="r23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grizelj</surname><given-names>I</given-names></name><name><surname>Cavka</surname><given-names>A</given-names></name><name><surname>Bian</surname><given-names>JT</given-names></name><name><surname>Szczurek</surname><given-names>M</given-names></name><name><surname>Robinson</surname><given-names>A</given-names></name><name><surname>Shinde</surname><given-names>S</given-names></name><etal/></person-group><article-title>Reduced flow-and acetylcholine-induced dilations in visceral
compared to subcutaneous adipose arterioles in human morbid
obesity</article-title><source>Microcirculation</source><year>2015</year><volume>22</volume><issue>1</issue><fpage>44</fpage><lpage>53</lpage><pub-id pub-id-type="pmid">25155427</pub-id></element-citation></ref><ref id="r24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Ciuceis</surname><given-names>C</given-names></name><name><surname>Porteri</surname><given-names>E</given-names></name><name><surname>Rizzoni</surname><given-names>D</given-names></name><name><surname>Corbellini</surname><given-names>C</given-names></name><name><surname>La Boria</surname><given-names>E</given-names></name><name><surname>Boari</surname><given-names>GE</given-names></name><etal/></person-group><article-title>Effects of weight loss on structural and functional alterations
of subcutaneous small arteries in obese patients</article-title><source>Hypertension</source><year>2011</year><volume>58</volume><issue>1</issue><fpage>29</fpage><lpage>36</lpage><pub-id pub-id-type="pmid">21555677</pub-id></element-citation></ref><ref id="r25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chan</surname><given-names>SY</given-names></name><name><surname>Mancini</surname><given-names>GB</given-names></name><name><surname>Kuramoto</surname><given-names>L</given-names></name><name><surname>Schulzer</surname><given-names>M</given-names></name><name><surname>Frohlich</surname><given-names>J</given-names></name><name><surname>Ignaszewski</surname><given-names>A</given-names></name><etal/></person-group><article-title>The prognostic importance of endothelial dysfunction and carotid
atheroma burden in patients with coronary artery disease</article-title><source>J Am Coll Cardiol</source><year>2003</year><volume>42</volume><issue>6</issue><fpage>1037</fpage><lpage>1043</lpage><pub-id pub-id-type="pmid">13678927</pub-id></element-citation></ref><ref id="r26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sugamata</surname><given-names>W</given-names></name><name><surname>Nakamura</surname><given-names>T</given-names></name><name><surname>Uematsu</surname><given-names>M</given-names></name><name><surname>Kitta</surname><given-names>Y</given-names></name><name><surname>Fujioka</surname><given-names>D</given-names></name><name><surname>Saito</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Combined assessment of flow-mediated dilation of the brachial
artery and brachial-ankle pulse wave velocity improves the prediction of
future coronary events in patients with chronic coronary artery
disease</article-title><source>J Cardiol</source><year>2014</year><volume>64</volume><issue>3</issue><fpage>179</fpage><lpage>184</lpage><pub-id pub-id-type="pmid">24556367</pub-id></element-citation></ref><ref id="r27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simova</surname><given-names>I</given-names></name><name><surname>Denchev</surname><given-names>S</given-names></name></person-group><article-title>Endothelial functional and structural impairment in patients with
different degrees of coronary artery disease development</article-title><source>Heart Vessels</source><year>2008</year><volume>23</volume><issue>5</issue><fpage>308</fpage><lpage>315</lpage><pub-id pub-id-type="pmid">18810579</pub-id></element-citation></ref><ref id="r28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuvin</surname><given-names>JT</given-names></name><name><surname>Patel</surname><given-names>AR</given-names></name><name><surname>Sliney</surname><given-names>KA</given-names></name><name><surname>Pandian</surname><given-names>NG</given-names></name><name><surname>Rand</surname><given-names>WM</given-names></name><name><surname>Udelson</surname><given-names>JE</given-names></name><etal/></person-group><article-title>Peripheral vascular endothelial function testing as a noninvasive
indicator of coronary artery disease</article-title><source>J Am Coll Cardiol</source><year>2001</year><volume>38</volume><issue>7</issue><fpage>1843</fpage><lpage>1849</lpage><pub-id pub-id-type="pmid">11738283</pub-id></element-citation></ref><ref id="r29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Guo</surname><given-names>F</given-names></name><name><surname>Li</surname><given-names>G</given-names></name><name><surname>Cao</surname><given-names>Y</given-names></name><name><surname>Fu</surname><given-names>H</given-names></name></person-group><article-title>Prognostic role of brachial reactivity in patients with ST
myocardial infarction after percutaneous coronary
intervention</article-title><source>Coron Artery Dis</source><year>2009</year><volume>20</volume><issue>7</issue><fpage>467</fpage><lpage>472</lpage><pub-id pub-id-type="pmid">19641459</pub-id></element-citation></ref><ref id="r30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kazmierski</surname><given-names>M</given-names></name><name><surname>Michalewska-Wludarczyk</surname><given-names>A</given-names></name><name><surname>Krzych</surname><given-names>LJ</given-names></name><name><surname>Tendera</surname><given-names>M</given-names></name></person-group><article-title>Diagnostic value of flow mediated dilatation measurement for
coronary artery lesions in men under 45 years of age</article-title><source>Cardiol J</source><year>2010</year><volume>17</volume><issue>3</issue><fpage>288</fpage><lpage>292</lpage><pub-id pub-id-type="pmid">20535720</pub-id></element-citation></ref><ref id="r31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kazmierski</surname><given-names>M</given-names></name><name><surname>Michalewska-Wludarczyk</surname><given-names>A</given-names></name><name><surname>Krzych</surname><given-names>LJ</given-names></name></person-group><article-title>Intima-media thickness and flow-mediated dilatation in the
diagnosis of coronary artery disease in perimenopausal women</article-title><source>Pol Arch Med Wewn</source><year>2010</year><volume>120</volume><issue>5</issue><fpage>181</fpage><lpage>188</lpage><pub-id pub-id-type="pmid">20502403</pub-id></element-citation></ref><ref id="r32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Inaba</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>JA</given-names></name><name><surname>Bergmann</surname><given-names>SR</given-names></name></person-group><article-title>Prediction of future cardiovascular outcomes by flow-mediated
vasodilatation of brachial artery: a metaanalysis</article-title><source>Int J Cardiovasc Imaging</source><year>2010</year><volume>26</volume><issue>6</issue><fpage>631</fpage><lpage>640</lpage><pub-id pub-id-type="pmid">20339920</pub-id></element-citation></ref><ref id="r33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patti</surname><given-names>G</given-names></name><name><surname>Pasceri</surname><given-names>V</given-names></name><name><surname>Melfi</surname><given-names>R</given-names></name><name><surname>Goffredo</surname><given-names>C</given-names></name><name><surname>Chello</surname><given-names>M</given-names></name><name><surname>D'Ambrosio</surname><given-names>A</given-names></name><etal/></person-group><article-title>Impaired flow-mediated dilation and risk of restenosis in
patients undergoing coronary stent implantation</article-title><source>Circulation</source><year>2005</year><volume>111</volume><issue>1</issue><fpage>70</fpage><lpage>75</lpage><pub-id pub-id-type="pmid">15630038</pub-id></element-citation></ref><ref id="r34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frick</surname><given-names>M</given-names></name><name><surname>Suessenbacher</surname><given-names>A</given-names></name><name><surname>Alber</surname><given-names>HF</given-names></name><name><surname>Dichtl</surname><given-names>W</given-names></name><name><surname>Ulmer</surname><given-names>H</given-names></name><name><surname>Pachinger</surname><given-names>O</given-names></name><etal/></person-group><article-title>Prognostic value of brachial artery endothelial function and wall
thickness</article-title><source>J Am Coll Cardiol</source><year>2005</year><volume>46</volume><issue>6</issue><fpage>1006</fpage><lpage>1010</lpage><pub-id pub-id-type="pmid">16168283</pub-id></element-citation></ref><ref id="r35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muiesan</surname><given-names>ML</given-names></name><name><surname>Salvetti</surname><given-names>M</given-names></name><name><surname>Paini</surname><given-names>A</given-names></name><name><surname>Monteduro</surname><given-names>C</given-names></name><name><surname>Galbassini</surname><given-names>G</given-names></name><name><surname>Poisa</surname><given-names>P</given-names></name><etal/></person-group><article-title>Prognostic role of flow-mediated dilatation of the brachial
artery in hypertensive patients</article-title><source>J Hypertens</source><year>2008</year><volume>26</volume><issue>8</issue><fpage>1612</fpage><lpage>1618</lpage><pub-id pub-id-type="pmid">18622240</pub-id></element-citation></ref><ref id="r36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meyer</surname><given-names>B</given-names></name><name><surname>M&#x000f6;rtl</surname><given-names>D</given-names></name><name><surname>Strecker</surname><given-names>K</given-names></name><name><surname>H&#x000fc;lsmann</surname><given-names>M</given-names></name><name><surname>Kulemann</surname><given-names>V</given-names></name><name><surname>Neunteufl</surname><given-names>T</given-names></name><etal/></person-group><article-title>Flow-mediated vasodilation predicts outcome in patients with
chronic heart failure: comparison with B-type natriuretic
peptide</article-title><source>J Am Coll Cardiol</source><year>2005</year><volume>46</volume><issue>6</issue><fpage>1011</fpage><lpage>1018</lpage><pub-id pub-id-type="pmid">16168284</pub-id></element-citation></ref><ref id="r37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leung</surname><given-names>FP</given-names></name><name><surname>Yung</surname><given-names>LM</given-names></name><name><surname>Laher</surname><given-names>I</given-names></name><name><surname>Yao</surname><given-names>X</given-names></name><name><surname>Chen</surname><given-names>ZY</given-names></name><name><surname>Huang</surname><given-names>Y</given-names></name></person-group><article-title>Exercise, vascular wall and cardiovascular diseases: an update
(Part 1)</article-title><source>Sports Med</source><year>2008</year><volume>38</volume><issue>12</issue><fpage>1009</fpage><lpage>1024</lpage><pub-id pub-id-type="pmid">19026018</pub-id></element-citation></ref><ref id="r38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Higashi</surname><given-names>Y</given-names></name><name><surname>Yoshizumi</surname><given-names>M</given-names></name></person-group><article-title>Exercise and endothelial function: role of endothelium-derived
nitric oxide and oxidative stress in healthy subjects and hypertensive
patients</article-title><source>Pharmacol Ther</source><year>2004</year><volume>102</volume><issue>1</issue><fpage>87</fpage><lpage>96</lpage><pub-id pub-id-type="pmid">15056500</pub-id></element-citation></ref><ref id="r39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kojda</surname><given-names>G</given-names></name><name><surname>Hambrecht</surname><given-names>R</given-names></name></person-group><article-title>Molecular mechanisms of vascular adaptations to exercise.
Physical activity as an effective antioxidant therapy</article-title><source>Cardiovasc Res</source><year>2005</year><volume>67</volume><issue>2</issue><fpage>187</fpage><lpage>197</lpage><pub-id pub-id-type="pmid">15935334</pub-id></element-citation></ref><ref id="r40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hambrecht</surname><given-names>R</given-names></name><name><surname>Adams</surname><given-names>V</given-names></name><name><surname>Erbs</surname><given-names>S</given-names></name><name><surname>Linke</surname><given-names>A</given-names></name><name><surname>Kr&#x000e4;nkel</surname><given-names>N</given-names></name><name><surname>Shu</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Regular physical activity improves endothelial function in
patients with coronary artery disease by increasing phosphorylation of
endothelial nitric oxide synthase</article-title><source>Circulation</source><year>2003</year><volume>107</volume><issue>25</issue><fpage>3152</fpage><lpage>3158</lpage><pub-id pub-id-type="pmid">12810615</pub-id></element-citation></ref><ref id="r41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maiorana</surname><given-names>A</given-names></name><name><surname>O'Driscoll</surname><given-names>G</given-names></name><name><surname>Cheetham</surname><given-names>C</given-names></name><name><surname>Dembo</surname><given-names>L</given-names></name><name><surname>Stanton</surname><given-names>K</given-names></name><name><surname>Goodman</surname><given-names>C</given-names></name><etal/></person-group><article-title>The effect of combined aerobic and resistance exercise training
on vascular function in type 2 diabetes</article-title><source>J Am Coll Cardiol</source><year>2001</year><volume>38</volume><issue>3</issue><fpage>860</fpage><lpage>866</lpage><pub-id pub-id-type="pmid">11527646</pub-id></element-citation></ref><ref id="r42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clarkson</surname><given-names>P</given-names></name><name><surname>Montgomery</surname><given-names>HE</given-names></name><name><surname>Mullen</surname><given-names>MJ</given-names></name><name><surname>Donald</surname><given-names>AE</given-names></name><name><surname>Powe</surname><given-names>AJ</given-names></name><name><surname>Bull</surname><given-names>T</given-names></name><etal/></person-group><article-title>Exercise training enhances endothelial function in young
men</article-title><source>J Am Coll Cardiol</source><year>1999</year><volume>33</volume><issue>5</issue><fpage>1379</fpage><lpage>1385</lpage><pub-id pub-id-type="pmid">10193742</pub-id></element-citation></ref><ref id="r43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bruning</surname><given-names>RS</given-names></name><name><surname>Sturek</surname><given-names>M</given-names></name></person-group><article-title>Benefits of exercise training on coronary blood flow in coronary
artery disease patients</article-title><source>Prog Cardiovasc Dis</source><year>2015</year><volume>57</volume><issue>5</issue><fpage>443</fpage><lpage>453</lpage><pub-id pub-id-type="pmid">25446554</pub-id></element-citation></ref><ref id="r44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hambrecht</surname><given-names>R</given-names></name><name><surname>Wolf</surname><given-names>A</given-names></name><name><surname>Gielen</surname><given-names>S</given-names></name><name><surname>Linke</surname><given-names>A</given-names></name><name><surname>Hofer</surname><given-names>J</given-names></name><name><surname>Erbs</surname><given-names>S</given-names></name><etal/></person-group><article-title>Effect of exercise on coronary endothelial function in patients
with coronary artery disease</article-title><source>N Engl J Med</source><year>2000</year><volume>342</volume><issue>7</issue><fpage>454</fpage><lpage>460</lpage><pub-id pub-id-type="pmid">10675425</pub-id></element-citation></ref><ref id="r45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siasos</surname><given-names>G</given-names></name><name><surname>Athanasiou</surname><given-names>D</given-names></name><name><surname>Terzis</surname><given-names>G</given-names></name><name><surname>Stasinaki</surname><given-names>A</given-names></name><name><surname>Oikonomou</surname><given-names>E</given-names></name><name><surname>Tsitkanou</surname><given-names>S</given-names></name><etal/></person-group><article-title>Acute effects of different types of aerobic exercise on
endothelial function and arterial stiffness</article-title><source>Eur J Prev Cardiol</source><year>2016</year><volume>23</volume><issue>14</issue><fpage>1565</fpage><lpage>1572</lpage><pub-id pub-id-type="pmid">27121699</pub-id></element-citation></ref><ref id="r46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Franklin</surname><given-names>NC</given-names></name><name><surname>Robinson</surname><given-names>AT</given-names></name><name><surname>Bian</surname><given-names>JT</given-names></name><name><surname>Ali</surname><given-names>MM</given-names></name><name><surname>Norkeviciute</surname><given-names>E</given-names></name><name><surname>McGinty</surname><given-names>P</given-names></name><etal/></person-group><article-title>Circuit resistance training attenuates acute exertion-induced
reductions in arterial function but not inflammation in obese
women</article-title><source>Metab Syndr Relat Disord</source><year>2015</year><volume>3</volume><issue>5</issue><fpage>227</fpage><lpage>234</lpage></element-citation></ref><ref id="r47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Green</surname><given-names>DJ</given-names></name><name><surname>Maiorana</surname><given-names>A</given-names></name><name><surname>O'Driscoll</surname><given-names>G</given-names></name><name><surname>Taylor</surname><given-names>R</given-names></name></person-group><article-title>Effect of exercise training on endothelium-derived nitric oxide
function in humans</article-title><source>J Physiol</source><year>2004</year><volume>561</volume><issue>1</issue><fpage>1</fpage><lpage>25</lpage><pub-id pub-id-type="pmid">15375191</pub-id></element-citation></ref><ref id="r48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Green</surname><given-names>DJ</given-names></name></person-group><article-title>Exercise training as vascular medicine: direct impacts on the
vasculature in humans</article-title><source>Exerc Sport Sci Rev</source><year>2009</year><volume>37</volume><issue>4</issue><fpage>196</fpage><lpage>202</lpage><pub-id pub-id-type="pmid">19955869</pub-id></element-citation></ref><ref id="r49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Collier</surname><given-names>SR</given-names></name><name><surname>Kanaley</surname><given-names>JA</given-names></name><name><surname>Carhart</surname><given-names>R Jr</given-names></name><name><surname>Frechette</surname><given-names>V</given-names></name><name><surname>Tobin</surname><given-names>MM</given-names></name><name><surname>Hall</surname><given-names>AK</given-names></name><etal/></person-group><article-title>Effect of 4 weeks of aerobic or resistance exercise training on
arterial stiffness, blood flow and blood pressure in pre- and stage-1
hypertensives</article-title><source>J Hum Hypertens</source><year>2008</year><volume>22</volume><issue>10</issue><fpage>678</fpage><lpage>686</lpage><pub-id pub-id-type="pmid">18432253</pub-id></element-citation></ref><ref id="r50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname><given-names>AT</given-names></name><name><surname>Franklin</surname><given-names>NC</given-names></name><name><surname>Norkeviciute</surname><given-names>E</given-names></name><name><surname>Bian</surname><given-names>JT</given-names></name><name><surname>Babana</surname><given-names>JC</given-names></name><name><surname>Szczurek</surname><given-names>MR</given-names></name><etal/></person-group><article-title>Improved arterial flow-mediated dilation after exertion involves
hydrogen peroxide in overweight and obese adults following aerobic exercise
training</article-title><source>J Hypertens</source><year>2016</year><volume>34</volume><issue>7</issue><fpage>1309</fpage><lpage>1316</lpage><pub-id pub-id-type="pmid">27137176</pub-id></element-citation></ref><ref id="r51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jacomini</surname><given-names>AM</given-names></name><name><surname>Souza</surname><given-names>HC</given-names></name><name><surname>Dias</surname><given-names>DS</given-names></name><name><surname>Brito</surname><given-names>JO</given-names></name><name><surname>Pinheiro</surname><given-names>LC</given-names></name><name><surname>Silva</surname><given-names>AB</given-names></name><etal/></person-group><article-title>Training status as a marker of the relationship between nitric
oxide, oxidative stress, and blood pressure in older adult
women</article-title><source>Oxid Med Cell Longev</source><year>2015</year><volume>2015</volume><fpage>8262383</fpage><lpage>8262383</lpage><pub-id pub-id-type="pmid">26697141</pub-id></element-citation></ref><ref id="r52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brawner</surname><given-names>CA</given-names></name><name><surname>Churilla</surname><given-names>JR</given-names></name><name><surname>Keteyian</surname><given-names>SJ</given-names></name></person-group><article-title>Prevalence of physical activity is lower among individuals with
chronic disease</article-title><source>Med Sci Sports Exerc</source><year>2016</year><volume>48</volume><issue>6</issue><fpage>1062</fpage><lpage>1067</lpage><pub-id pub-id-type="pmid">26741117</pub-id></element-citation></ref><ref id="r53"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmidt</surname><given-names>W</given-names></name><name><surname>Endres</surname><given-names>M</given-names></name><name><surname>Dimeo</surname><given-names>F</given-names></name><name><surname>Jungehulsing</surname><given-names>GJ</given-names></name></person-group><article-title>Train the vessel, gain the brain: Physical activity and vessel
function and the impact on stroke prevention and outcome in cerebrovascular
disease</article-title><source>Cerebrovasc Dis</source><year>2013</year><volume>35</volume><issue>4</issue><fpage>303</fpage><lpage>312</lpage><pub-id pub-id-type="pmid">23594423</pub-id></element-citation></ref><ref id="r54"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hambrecht</surname><given-names>R</given-names></name><name><surname>Fiehn</surname><given-names>E</given-names></name><name><surname>Weigl</surname><given-names>C</given-names></name><name><surname>Gielen</surname><given-names>S</given-names></name><name><surname>Hamann</surname><given-names>C</given-names></name><name><surname>Kaiser</surname><given-names>R</given-names></name><etal/></person-group><article-title>Regular physical exercise corrects endothelial dysfunction and
improves exercise capacity in patients with chronic heart
failure</article-title><source>Circulation</source><year>1998</year><volume>98</volume><fpage>2709</fpage><lpage>2715</lpage><pub-id pub-id-type="pmid">9851957</pub-id></element-citation></ref><ref id="r55"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duncker</surname><given-names>DJ</given-names></name><name><surname>Bache</surname><given-names>RJ</given-names></name></person-group><article-title>Regulation of coronary blood flow during exercise</article-title><source>Physiol Rev</source><year>2008</year><volume>88</volume><issue>3</issue><fpage>1009</fpage><lpage>1086</lpage><pub-id pub-id-type="pmid">18626066</pub-id></element-citation></ref><ref id="r56"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Humphreys</surname><given-names>RE</given-names></name><name><surname>Green</surname><given-names>DJ</given-names></name><name><surname>Cable</surname><given-names>NT</given-names></name><name><surname>Thijssen</surname><given-names>DH</given-names></name><name><surname>Dawson</surname><given-names>EA</given-names></name></person-group><article-title>Low-flow mediated constriction: the yin to FMD's
yang?</article-title><source>Expert Rev Cardiovasc Ther</source><year>2014</year><volume>12</volume><issue>5</issue><fpage>557</fpage><lpage>564</lpage><pub-id pub-id-type="pmid">24745959</pub-id></element-citation></ref><ref id="r57"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bacon</surname><given-names>SL</given-names></name><name><surname>Sherwood</surname><given-names>A</given-names></name><name><surname>Hinderliter</surname><given-names>A</given-names></name><name><surname>Plourde</surname><given-names>A</given-names></name><name><surname>Pierson</surname><given-names>L</given-names></name><name><surname>Blumenthal</surname><given-names>JA</given-names></name></person-group><article-title>The influence of endothelial function and myocardial ischemia on
peak oxygen consumption in patients with coronary artery
disease</article-title><source>Int J Vasc Med</source><year>2012</year><volume>2012</volume><fpage>274381</fpage><lpage>274381</lpage><pub-id pub-id-type="pmid">23097703</pub-id></element-citation></ref><ref id="r58"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luk</surname><given-names>TH</given-names></name><name><surname>Dai</surname><given-names>YL</given-names></name><name><surname>Siu</surname><given-names>CW</given-names></name><name><surname>Yiu</surname><given-names>KH</given-names></name><name><surname>Chan</surname><given-names>HT</given-names></name><name><surname>Lee</surname><given-names>SW</given-names></name><etal/></person-group><article-title>Effect of exercise training on vascular endothelial function in
patients with stable coronary artery disease: a randomized controlled
trial</article-title><source>Eur J Prev Cardiol</source><year>2012</year><volume>19</volume><issue>4</issue><fpage>830</fpage><lpage>839</lpage><pub-id pub-id-type="pmid">21724681</pub-id></element-citation></ref><ref id="r59"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>C</given-names></name><name><surname>Choi</surname><given-names>HE</given-names></name><name><surname>Jung</surname><given-names>H</given-names></name><name><surname>Kang</surname><given-names>SH</given-names></name><name><surname>Kim</surname><given-names>JH</given-names></name><name><surname>Byun</surname><given-names>YS</given-names></name></person-group><article-title>Impact of aerobic exercise training on endothelial function in
acute coronary syndrome</article-title><source>Ann Rehabil Med</source><year>2014</year><volume>38</volume><issue>3</issue><fpage>388</fpage><lpage>395</lpage><pub-id pub-id-type="pmid">25024964</pub-id></element-citation></ref><ref id="r60"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Craenenbroeck</surname><given-names>EM</given-names></name><name><surname>Frederix</surname><given-names>G</given-names></name><name><surname>Pattyn</surname><given-names>N</given-names></name><name><surname>Beckers</surname><given-names>P</given-names></name><name><surname>Van Craenenbroeck</surname><given-names>AH</given-names></name><name><surname>Gevaert</surname><given-names>A</given-names></name><etal/></person-group><article-title>Effects of aerobic interval training and continuous training on
cellular markers of endothelial integrity in coronary artery disease: a
SAINTEX-CAD substudy</article-title><source>Am J Physiol Heart Circ Physiol</source><year>2015</year><volume>309</volume><issue>11</issue><fpage>H1876</fpage><lpage>H1882</lpage><pub-id pub-id-type="pmid">26453327</pub-id></element-citation></ref><ref id="r61"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Currie</surname><given-names>KD</given-names></name><name><surname>Dubberley</surname><given-names>JB</given-names></name><name><surname>McKelvie</surname><given-names>RS</given-names></name><name><surname>MacDonald</surname><given-names>MJ</given-names></name></person-group><article-title>Low-volume, high-intensity interval training in patients with
CAD</article-title><source>Med Sci Sports Exerc</source><year>2013</year><volume>45</volume><issue>8</issue><fpage>1436</fpage><lpage>1442</lpage><pub-id pub-id-type="pmid">23470301</pub-id></element-citation></ref><ref id="r62"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walsh</surname><given-names>JH</given-names></name><name><surname>Bilsborough</surname><given-names>W</given-names></name><name><surname>Maiorana</surname><given-names>A</given-names></name><name><surname>Best</surname><given-names>M</given-names></name><name><surname>O'Driscoll</surname><given-names>GJ</given-names></name><name><surname>Taylor</surname><given-names>RR</given-names></name><etal/></person-group><article-title>Exercise training improves conduit vessel function in patients
with coronary artery disease</article-title><source>J Appl Physiol</source><year>2003</year><volume>95</volume><issue>1</issue><fpage>20</fpage><lpage>25</lpage><pub-id pub-id-type="pmid">12794092</pub-id></element-citation></ref><ref id="r63"><label>63</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harris</surname><given-names>LM</given-names></name><name><surname>Faggioli</surname><given-names>GL</given-names></name><name><surname>Shah</surname><given-names>R</given-names></name><name><surname>Koerner</surname><given-names>N</given-names></name><name><surname>Lillis</surname><given-names>L</given-names></name><name><surname>Dandona</surname><given-names>P</given-names></name><etal/></person-group><article-title>Vascular reactivity in patients with peripheral vascular
disease</article-title><source>Am J Cardiol</source><year>1995</year><volume>76</volume><fpage>207</fpage><lpage>212</lpage><pub-id pub-id-type="pmid">7611168</pub-id></element-citation></ref><ref id="r64"><label>64</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Januszek</surname><given-names>R</given-names></name><name><surname>Mika</surname><given-names>P</given-names></name><name><surname>Konik</surname><given-names>A</given-names></name><name><surname>Petriczek</surname><given-names>T</given-names></name><name><surname>Nowobilski</surname><given-names>R</given-names></name><name><surname>Nizankowski</surname><given-names>R</given-names></name></person-group><article-title>Effect of treadmill training on endothelial function and walking
abilities in patients with peripheral arterial disease</article-title><source>J Cardiol</source><year>2014</year><volume>64</volume><issue>2</issue><fpage>145</fpage><lpage>151</lpage><pub-id pub-id-type="pmid">24438856</pub-id></element-citation></ref><ref id="r65"><label>65</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Januszek</surname><given-names>R</given-names></name><name><surname>Mika</surname><given-names>P</given-names></name><name><surname>Nowobilski</surname><given-names>R</given-names></name><name><surname>Maga</surname><given-names>P</given-names></name><name><surname>Nizankowski</surname><given-names>R</given-names></name></person-group><article-title>The improvement of walking abilities and endothelial function
after the supervised training treadmill program (STTP) in patients with
peripheral artery disease (PAD) is not related to prostacyclin and
thromboxane release</article-title><source>Int J Cardiol</source><year>2016</year><volume>222</volume><fpage>813</fpage><lpage>818</lpage><pub-id pub-id-type="pmid">27522380</pub-id></element-citation></ref><ref id="r66"><label>66</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parmenter</surname><given-names>BJ</given-names></name><name><surname>Dieberg</surname><given-names>G</given-names></name><name><surname>Smart</surname><given-names>NA</given-names></name></person-group><article-title>Exercise training for management of peripheral arterial disease:
a systematic review and meta-analysis</article-title><source>Sports Med</source><year>2015</year><volume>45</volume><issue>2</issue><fpage>231</fpage><lpage>244</lpage><pub-id pub-id-type="pmid">25230780</pub-id></element-citation></ref><ref id="r67"><label>67</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Santos-Garcia</surname><given-names>D</given-names></name><name><surname>Blanco</surname><given-names>M</given-names></name><name><surname>Serena</surname><given-names>J</given-names></name><name><surname>Arias</surname><given-names>S</given-names></name><name><surname>Milll&#x000e1;n</surname><given-names>M</given-names></name><name><surname>Rodr&#x000ed;guez-Y&#x000e1;&#x000f1;ez</surname><given-names>M</given-names></name><etal/></person-group><article-title>Brachial arterial flow mediated dilation in acute ischemic
stroke</article-title><source>Eur J Neurol</source><year>2009</year><volume>16</volume><issue>6</issue><fpage>684</fpage><lpage>690</lpage><pub-id pub-id-type="pmid">19236459</pub-id></element-citation></ref><ref id="r68"><label>68</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Santos-Garcia</surname><given-names>D</given-names></name><name><surname>Blanco</surname><given-names>M</given-names></name><name><surname>Serena</surname><given-names>J</given-names></name><name><surname>Rodr&#x000ed;guez-Y&#x000e1;&#x000f1;ez</surname><given-names>M</given-names></name><name><surname>Leira</surname><given-names>R</given-names></name><name><surname>Castillo</surname><given-names>J</given-names></name></person-group><article-title>Impaired brachial flow-mediated dilation is a predictor of a
newonset vascular event after stroke</article-title><source>Cerebrovasc Dis</source><year>2011</year><volume>32</volume><issue>2</issue><fpage>155</fpage><lpage>162</lpage><pub-id pub-id-type="pmid">21778713</pub-id></element-citation></ref><ref id="r69"><label>69</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soares-Miranda</surname><given-names>L</given-names></name><name><surname>Siscovick</surname><given-names>DS</given-names></name><name><surname>Psaty</surname><given-names>BM</given-names></name><name><surname>Longstreth</surname><given-names>WT</given-names></name><name><surname>Mozaffarian</surname><given-names>D</given-names></name></person-group><article-title>Physical activity and risk of coronary heart disease and stroke
in older adults</article-title><source>Circulation</source><year>2016</year><volume>133</volume><issue>2</issue><fpage>147</fpage><lpage>155</lpage><pub-id pub-id-type="pmid">26538582</pub-id></element-citation></ref><ref id="r70"><label>70</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sattelmair</surname><given-names>JR</given-names></name><name><surname>Kurth</surname><given-names>T</given-names></name><name><surname>Buring</surname><given-names>JE</given-names></name><name><surname>Lee</surname><given-names>IMC-NP</given-names></name></person-group><article-title>Physical activity and risk of stroke in women</article-title><source>Stroke</source><comment>Internet</comment><year>2010</year><volume>41</volume><fpage>1243</fpage><lpage>1250</lpage><pub-id pub-id-type="pmid">20371746</pub-id></element-citation></ref><ref id="r71"><label>71</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Billinger</surname><given-names>SA</given-names></name><name><surname>Mattlage</surname><given-names>AE</given-names></name><name><surname>Ashenden</surname><given-names>AL</given-names></name><name><surname>Lentz</surname><given-names>A</given-names></name><name><surname>Harter</surname><given-names>G</given-names></name></person-group><article-title>Aerobic exercise in subacute stroke improves cardiovascular
health and physical performance</article-title><source>J Neurol Phys Ther</source><year>2012</year><volume>36</volume><issue>4</issue><fpage>159</fpage><lpage>165</lpage><pub-id pub-id-type="pmid">23111686</pub-id></element-citation></ref><ref id="r72"><label>72</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takatori</surname><given-names>K</given-names></name><name><surname>Matsumoto</surname><given-names>D</given-names></name><name><surname>Okada</surname><given-names>Y</given-names></name><name><surname>Nakamura</surname><given-names>J</given-names></name><name><surname>Shomoto</surname><given-names>K</given-names></name></person-group><article-title>Effect of intensive rehabilitation on physical function and
arterial function in community-dwelling chronic stroke
survivors</article-title><source>Top Stroke Rehabil</source><year>2012</year><volume>19</volume><issue>5</issue><fpage>377</fpage><lpage>383</lpage><pub-id pub-id-type="pmid">22982824</pub-id></element-citation></ref><ref id="r73"><label>73</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verma</surname><given-names>S</given-names></name><name><surname>Buchanan</surname><given-names>MR</given-names></name><name><surname>Anderson</surname><given-names>TJ</given-names></name></person-group><article-title>Endothelial function testing as a biomarker of vascular
disease</article-title><source>Circulation</source><year>2003</year><volume>108</volume><issue>17</issue><fpage>20549</fpage><lpage>20549</lpage></element-citation></ref><ref id="r74"><label>74</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sangalli</surname><given-names>F</given-names></name><name><surname>Guazzi</surname><given-names>M</given-names></name><name><surname>Senni</surname><given-names>S</given-names></name><name><surname>Sala</surname><given-names>W</given-names></name><name><surname>Caruso</surname><given-names>R</given-names></name><name><surname>Costa</surname><given-names>MC</given-names></name><etal/></person-group><article-title>Assessing endothelial responsiveness after cardiopulmonary
bypass: insights on different perfusion modalities</article-title><source>J Cardiothorac Vasc Anesth</source><year>2015</year><volume>29</volume><issue>4</issue><fpage>912</fpage><lpage>916</lpage><pub-id pub-id-type="pmid">25661644</pub-id></element-citation></ref><ref id="r75"><label>75</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gokce</surname><given-names>N</given-names></name><name><surname>Keaney</surname><given-names>JF Jr</given-names></name><name><surname>Hunter</surname><given-names>LM</given-names></name><name><surname>Watkins</surname><given-names>MT</given-names></name><name><surname>Menzoian</surname><given-names>JO</given-names></name><name><surname>Vita</surname><given-names>JA</given-names></name></person-group><article-title>Risk stratification for postoperative cardiovascular events via
noninvasive assessment of endothelial function: a prospective
study</article-title><source>Circulation</source><year>2002</year><volume>105</volume><issue>13</issue><fpage>1567</fpage><lpage>1572</lpage><pub-id pub-id-type="pmid">11927524</pub-id></element-citation></ref><ref id="r76"><label>76</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schier</surname><given-names>R</given-names></name><name><surname>Hinkelbein</surname><given-names>J</given-names></name><name><surname>Marcus</surname><given-names>H</given-names></name><name><surname>Mehran</surname><given-names>R</given-names></name><name><surname>El-Zein</surname><given-names>R</given-names></name><name><surname>Hofstetter</surname><given-names>W</given-names></name><etal/></person-group><article-title>Preoperative microvascular dysfunction: a prospective,
observational study expanding risk assessment strategies in major thoracic
surgery</article-title><source>Ann Thorac Surg</source><year>2012</year><volume>94</volume><issue>1</issue><fpage>226</fpage><lpage>233</lpage><pub-id pub-id-type="pmid">22571880</pub-id></element-citation></ref></ref-list></back></article>